BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7. [DOI: 10.1038/366704a0] [Cited by in Crossref: 2308] [Cited by in F6Publishing: 2192] [Article Influence: 79.6] [Reference Citation Analysis]
Number Citing Articles
1 Tanabe A, Shimizu R, Osawa Y, Suzuki M, Ito S, Goto M, Pastene LA, Fujise Y, Sahara H. Age estimation by DNA methylation in the Antarctic minke whale. Fish Sci 2020;86:35-41. [DOI: 10.1007/s12562-019-01371-7] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pei XH, Bai F, Tsutsui T, Kiyokawa H, Xiong Y. Genetic evidence for functional dependency of p18Ink4c on Cdk4. Mol Cell Biol 2004;24:6653-64. [PMID: 15254233 DOI: 10.1128/MCB.24.15.6653-6664.2004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
3 Grimminger CM, Danenberg PV. Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. Eur Arch Otorhinolaryngol 2011;268:5-16. [PMID: 20827554 DOI: 10.1007/s00405-010-1369-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
4 Wolf JK, Kim T, Fightmaster D, Bodurka D, Gershenson DM, Mills G, Wharton J. Growth Suppression of Human Ovarian Cancer Cell Lines by the Introduction of a p16 Gene via a Recombinant Adenovirus. Gynecologic Oncology 1999;73:27-34. [DOI: 10.1006/gyno.1998.5259] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
5 Poirier F, Pontet M, Labas V, le Caer JP, Sghiouar-Imam N, Raphael M, Caron M, Joubert-Caron R. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5'-azycytidine. Electrophoresis. 2001;22:1867-1877. [PMID: 11425244 DOI: 10.1002/1522-2683(200105)22:9%3C1867::AID-ELPS1867%3E3.0.CO;2-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Pabst T, Peters UR, Tinguely M, Sci-waller J, Tschan M, Aebi S, Vonlanthen S, Borisch B, Betticher DC, Zimmermann A, Tobler A, Fey MF. Divergent Expression of Cclin-Dependent Kinase Inhibitors (CKI) And p14 ARF /p16β in Non-Hodgkin's Lymphomas and Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 2009;37:639-48. [DOI: 10.3109/10428190009058520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Chandra A, Rajawat J. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics. Int J Mol Sci 2021;22:3553. [PMID: 33805567 DOI: 10.3390/ijms22073553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Loar JW, Seiser RM, Sundberg AE, Sagerson HJ, Ilias N, Zobel-Thropp P, Craig EA, Lycan DE. Genetic and biochemical interactions among Yar1, Ltv1 and Rps3 define novel links between environmental stress and ribosome biogenesis in Saccharomyces cerevisiae. Genetics 2004;168:1877-89. [PMID: 15611164 DOI: 10.1534/genetics.104.032656] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
9 Hengstschläger M, Pfeilstöcker M, Wawra E. Identification of leukaemic cells in bone marrow and blood samples by a new cytofluorometric assay. Br J Cancer 1996;73:1237-40. [PMID: 8630285 DOI: 10.1038/bjc.1996.237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 Al-Khalaf HH, Nallar SC, Kalvakolanu DV, Aboussekhra A. p16INK4A enhances the transcriptional and the apoptotic functions of p53 through DNA-dependent interaction. Mol Carcinog 2017;56:1687-702. [PMID: 28218424 DOI: 10.1002/mc.22627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
11 Nieto-Sampedro M, Valle-Argos B, Gómez-Nicola D, Fernández-Mayoralas A, Nieto-Díaz M. Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. Clin Med Insights Oncol. 2011;5:265-314. [PMID: 22084619 DOI: 10.4137/cmo.s7685] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
12 Li Z, Zou W, Zhang J, Zhang Y, Xu Q, Li S, Chen C. Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer. Front Pharmacol 2020;11:580251. [PMID: 33364954 DOI: 10.3389/fphar.2020.580251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Keller-melchior R, Schmidt R, Piepkorn M. Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic Lesions. Journal of Investigative Dermatology 1998;110:932-8. [DOI: 10.1046/j.1523-1747.1998.00211.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
14 Fernàndez V, Hartmann E, Ott G, Campo E, Rosenwald A. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol. 2005;23:6364-6369. [PMID: 16155021 DOI: 10.1200/jco.2005.05.019] [Cited by in Crossref: 137] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
15 Soufir N, Ribojad M, Magnaldo T, Thibaudeau O, Delestaing G, Daya-grosjean L, Rivet J, Sarasin A, Basset-seguin N. Germline and Somatic Mutations of the INK4a-ARF Gene in a Xeroderma Pigmentosum Group C Patient. Journal of Investigative Dermatology 2002;119:1355-60. [DOI: 10.1046/j.1523-1747.2002.19603.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guan RJ, Fu Y, Holt PR, Pardee AB. Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology. 1999;116:1063-1071. [PMID: 10220498 DOI: 10.1016/s0016-5085(99)70009-0] [Cited by in Crossref: 82] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
17 Rizos H, Darmanian AP, Holland EA, Mann GJ, Kefford RF. Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF. Journal of Biological Chemistry 2001;276:41424-34. [DOI: 10.1074/jbc.m105299200] [Cited by in Crossref: 78] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
18 Raffel C, Ueki K, Harsh GR, Louis DN. The Multiple Tumor Suppressor 1/Cyclin-dependent Kinase Inhibitor 2 Gene in Human Central Nervous System Primitive Neuroectodermal Tumor. Neurosurgery 1995;36:971-5. [DOI: 10.1227/00006123-199505000-00013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
19 Belden CJ, Valdes PA, Ran C, Pastel DA, Harris BT, Fadul CE, Israel MA, Paulsen K, Roberts DW. Genetics of glioblastoma: a window into its imaging and histopathologic variability. Radiographics 2011;31:1717-40. [PMID: 21997991 DOI: 10.1148/rg.316115512] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
20 Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin W, Pour PM, Song H, Gold B, Batra SK, Weghorst CM. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16INK4a and p15INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells. Gene 2001;278:235-43. [DOI: 10.1016/s0378-1119(01)00728-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 He BL, Xu N, Li YL, Pan CY, Cao R, Liao LB, Yin CX, Lan YQ, Lu ZY, Huang JX, Zhou HS, Liu QF, Liu XL. [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion]. Zhonghua Xue Ye Xue Za Zhi 2017;38:204-9. [PMID: 28395443 DOI: 10.3760/cma.j.issn.0253-2727.2017.03.006] [Reference Citation Analysis]
22 Saab J, Santos-Zabala ML, Loda M, Stack EC, Hollmann TJ. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi. Am J Dermatopathol 2018;40:259-64. [PMID: 28654463 DOI: 10.1097/DAD.0000000000000939] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Perdomo HAG, Zapata-Copete JA, Sanchez A. Molecular alterations associated with prostate cancer. Cent European J Urol 2018;71:168-76. [PMID: 30038806 DOI: 10.5173/ceju.2018.1583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
24 Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol 2002;55:669-75. [PMID: 12194996 DOI: 10.1136/jcp.55.9.669] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
25 Gjerset RA. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer. J Mol Histol 2006;37:239-51. [PMID: 16855788 DOI: 10.1007/s10735-006-9040-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
26 Wu T, Wu L. The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer. Front Oncol 2021;11:655630. [PMID: 34136392 DOI: 10.3389/fonc.2021.655630] [Reference Citation Analysis]
27 Kondo K, Takahashi Y, Hirose Y, Nagao T, Tsuyuguchi M, Hashimoto M, Ochiai A, Monden Y, Tangoku A. The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. Lung Cancer 2006;53:295-302. [PMID: 16828922 DOI: 10.1016/j.lungcan.2006.05.022] [Cited by in Crossref: 99] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
28 Lukas J, Bartkova J, Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 1996;16:6917-25. [PMID: 8943347 DOI: 10.1128/MCB.16.12.6917] [Cited by in Crossref: 224] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
29 Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Hayakawa T. Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues. Cancer Letters 1995;97:241-7. [DOI: 10.1016/0304-3835(95)03981-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
30 Obaya AJ, Mateyak MK, Sedivy JM. Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene. 1999;18:2934-2941. [PMID: 10378690 DOI: 10.1038/sj.onc.1202749] [Cited by in Crossref: 148] [Cited by in F6Publishing: 159] [Article Influence: 6.4] [Reference Citation Analysis]
31 Lees E. Cyclin dependent kinase regulation. Current Opinion in Cell Biology 1995;7:773-80. [DOI: 10.1016/0955-0674(95)80060-3] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 7.1] [Reference Citation Analysis]
32 Saegusa M, Okayasu I. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas. Br J Cancer 1999;80:51-8. [PMID: 10389977 DOI: 10.1038/sj.bjc.6690320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
33 Platz A, Sevigny P, Norberg T, Ring P, Lagerlöf B, Ringborg U. Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 1996;74:936-41. [PMID: 8826861 DOI: 10.1038/bjc.1996.460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
34 Sahebali S, Depuydt CE, Segers K, Moeneclaey LM, Vereecken AJ, Van Marck E, Bogers JJ. P16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004;108:871-6. [DOI: 10.1002/ijc.11589] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
35 Bressac-de-paillerets B, Avril M, Chompret A, Demenais F. Genetic and environmental factors in cutaneous malignant melanoma. Biochimie 2002;84:67-74. [DOI: 10.1016/s0300-9084(01)01360-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
36 DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A 1997;94:7245-50. [PMID: 9207076 DOI: 10.1073/pnas.94.14.7245] [Cited by in Crossref: 440] [Cited by in F6Publishing: 492] [Article Influence: 17.6] [Reference Citation Analysis]
37 von Keyserling H, Kühn W, Schneider A, Bergmann T, Kaufmann AM. p16INK⁴a and p14ARF mRNA expression in Pap smears is age-related. Mod Pathol 2012;25:465-70. [PMID: 22080060 DOI: 10.1038/modpathol.2011.179] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
38 Serizawa H. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH. J Biol Chem 1998;273:5427-30. [PMID: 9488660 DOI: 10.1074/jbc.273.10.5427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
39 Lu J, Wood D, Ingley E, Koks S, Wong D. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma. Mol Biol Rep 2021;48:3637-47. [PMID: 33893924 DOI: 10.1007/s11033-021-06362-5] [Reference Citation Analysis]
40 Fernández-piqueras J, Santos J, Pérez de Castro I, Meléndez B, Martínez B, Robledo M, Rivas C, Benítez J. Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage. Cancer Genetics and Cytogenetics 1997;98:63-8. [DOI: 10.1016/s0165-4608(96)00400-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
41 Negishi Y, Ui N, Nakajima M, Kawashima K, Maruyama K, Takizawa T, Endo H. p21Cip-1/SDI-1/WAF-1 Gene Is Involved in Chondrogenic Differentiation of ATDC5 Cells in Vitro. Journal of Biological Chemistry 2001;276:33249-56. [DOI: 10.1074/jbc.m010127200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
42 Foley E, O'farrell PH, Sprenger F. Rux is a cyclin-dependent kinase inhibitor (CKI) specific for mitotic cyclin–Cdk complexes. Current Biology 1999;9:1392-402. [DOI: 10.1016/s0960-9822(00)80084-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
43 Wong H, Riabowol K. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Experimental Gerontology 1996;31:311-25. [DOI: 10.1016/0531-5565(95)00025-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 2.7] [Reference Citation Analysis]
44 Macnicol M, Schulman H. Cross-talk between protein kinase C and multifunctional Ca2+/calmodulin-dependent protein kinase. Journal of Biological Chemistry 1992;267:12197-201. [DOI: 10.1016/s0021-9258(19)49824-4] [Cited by in Crossref: 58] [Article Influence: 1.9] [Reference Citation Analysis]
45 Moro A, Calixto A, Suárez E, Araña M, Perea S. Differential Expression of the p27Kip1mRNA in IFN-Sensitive and Resistant Cell Lines. Biochemical and Biophysical Research Communications 1998;245:752-6. [DOI: 10.1006/bbrc.1998.8512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
46 Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group. CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 2007;127:1234-43. [PMID: 17218939 DOI: 10.1038/sj.jid.5700689] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
47 Pollack IF, Hamilton RL, Finkelstein SD, Lieberman F. Molecular abnormalities and correlations with tumor response and outcome in glioma patients. Neuroimaging Clinics of North America 2002;12:627-39. [DOI: 10.1016/s1052-5149(02)00030-8] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
48 Hofer TP, Frankenberger M, Staples KJ, Ziegler-Heitbrock L. Expression of p57-Kip2 in monocytes and macrophages. Immunobiology 2006;211:455-62. [PMID: 16920485 DOI: 10.1016/j.imbio.2006.05.018] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Pisick E, Salgia R. Molecular biology of malignant mesothelioma: a review. Hematol Oncol Clin North Am 2005;19:997-1023, v. [PMID: 16325120 DOI: 10.1016/j.hoc.2005.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
50 Fang Y, Gong AY, Haller ST, Dworkin LD, Liu Z, Gong R. The ageing kidney: Molecular mechanisms and clinical implications. Ageing Res Rev 2020;63:101151. [PMID: 32835891 DOI: 10.1016/j.arr.2020.101151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Betz B, Florl AR, Seifert H, Dall P, Schulz WA, Niederacher D. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer. Hum Mutat 2004;23:612-20. [DOI: 10.1002/humu.20033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
52 Chua SS, Ma Z, Ngan E, Tsai SY. Cdc25B as a steroid receptor coactivator. Vitam Horm 2004;68:231-56. [PMID: 15193457 DOI: 10.1016/S0083-6729(04)68008-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
53 Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochem Biophys Res Commun 1998;247:146-53. [PMID: 9636670 DOI: 10.1006/bbrc.1998.8497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
54 Casas S, Ollila J, Aventín A, Vihinen M, Sierra J, Knuutila S. Changes in apoptosis-related pathways in acute myelocytic leukemia. Cancer Genet Cytogenet 2003;146:89-101. [PMID: 14553942 DOI: 10.1016/s0165-4608(03)00102-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
55 Robl B, Pauli C, Botter SM, Bode-Lesniewska B, Fuchs B. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer 2015;15:379. [PMID: 25956431 DOI: 10.1186/s12885-015-1397-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
56 Yuan F, Ma Y, You P, Lin W, Lu H, Yu Y, Wang X, Jiang J, Yang P, Ma Q, Tao T. A novel role of proteasomal β1 subunit in tumorigenesis. Biosci Rep 2013;33:e00050. [PMID: 23725357 DOI: 10.1042/BSR20130013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
57 Sheikh BN, Phipson B, El-saafin F, Vanyai HK, Downer NL, Bird MJ, Kueh AJ, May RE, Smyth GK, Voss AK, Thomas T. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway. Oncogene 2015;34:5807-20. [DOI: 10.1038/onc.2015.33] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
58 Brown MA. Tumor suppressor genes and human cancer. Adv Genet. 1997;36:45-135. [PMID: 9348653 DOI: 10.1016/s0065-2660(08)60307-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
59 Park MT, Lee SJ. Cell cycle and cancer. J Biochem Mol Biol. 2003;36:60-65. [PMID: 12542976 DOI: 10.5483/BMBRep.2003.36.1.060] [Cited by in Crossref: 57] [Cited by in F6Publishing: 63] [Article Influence: 3.0] [Reference Citation Analysis]
60 Nikolic N, Carkic J, Ilic Dimitrijevic I, Eljabo N, Radunovic M, Anicic B, Tanic N, Falk M, Milasin J. P14 methylation: an epigenetic signature of salivary gland mucoepidermoid carcinoma in the Serbian population. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2018;125:52-8. [DOI: 10.1016/j.oooo.2017.09.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Huang YC, Hung WC, Chen WT, Jiang WH, Yu HS, Chai CY. Effects of MEK and DNMT inhibitors on arsenic-treated human uroepithelial cells in relation to Cyclin-D1 and p16. Toxicol Lett 2011;200:59-66. [PMID: 21040761 DOI: 10.1016/j.toxlet.2010.10.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
62 Harada H, Nakagawa K, Saito M, Kohno S, Nagato S, Furukawa K, Kumon Y, Hamada K, Ohnishi T. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells. Cancer Letters 2003;191:109-19. [DOI: 10.1016/s0304-3835(02)00592-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
63 Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994;78:67-74. [PMID: 8033213 DOI: 10.1016/0092-8674(94)90573-8] [Cited by in Crossref: 1395] [Cited by in F6Publishing: 1399] [Article Influence: 49.8] [Reference Citation Analysis]
64 Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev 1999;13:2670-7. [PMID: 10541553 DOI: 10.1101/gad.13.20.2670] [Cited by in Crossref: 325] [Cited by in F6Publishing: 333] [Article Influence: 14.1] [Reference Citation Analysis]
65 Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486-541. [PMID: 29362479 DOI: 10.1038/s41418-017-0012-4] [Cited by in Crossref: 1577] [Cited by in F6Publishing: 1520] [Article Influence: 394.3] [Reference Citation Analysis]
66 Akao T, Kakehi Y, Itoh N, Ozdemir E, Shimizu T, Tachibana A, Sasaki MS, Yoshida O. A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers. Jpn J Cancer Res 1997;88:1078-86. [PMID: 9439683 DOI: 10.1111/j.1349-7006.1997.tb00332.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
67 Bean SM, Meara RS, Vollmer RT, Conner MG, Crowe DR, Novak L, Eltoum IA, Robboy SJ, Chhieng DC. p16 Improves Interobserver Agreement in Diagnosis of Anal Intraepithelial Neoplasia. Journal of Lower Genital Tract Disease 2009;13:145-53. [DOI: 10.1097/lgt.0b013e3181934486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
68 Shao ZM, Nguyen M. Tumor-specific DNA in plasma of breast cancer patients. Anticancer Drugs 2002;13:353-7. [PMID: 11984080 DOI: 10.1097/00001813-200204000-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
69 Debniak T. Familial malignant melanoma - overview. Hered Cancer Clin Pract 2004;2:123-9. [PMID: 20233466 DOI: 10.1186/1897-4287-2-3-123] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
70 Vesely J, Havlicek L, Strnad M, Blow JJ, Donella-deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, Meijer L. Inhibition of Cyclin-Dependent Kinases by Purine Analogues. Eur J Biochem 1994;224:771-86. [DOI: 10.1111/j.1432-1033.1994.00771.x] [Cited by in Crossref: 440] [Cited by in F6Publishing: 443] [Article Influence: 15.7] [Reference Citation Analysis]
71 Lee JJ, Ko E, Cho J, Park HY, Lee JE, Nam SJ, Kim DH, Cho EY. Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR. Korean J Pathol 2012;46:554-61. [PMID: 23323106 DOI: 10.4132/KoreanJPathol.2012.46.6.554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
72 Re M, Gioacchini FM, Bajraktari A, Tomasetti M, Kaleci S, Rubini C, Bertini A, Magliulo G, Pasquini E. Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review. Eur Arch Otorhinolaryngol 2017;274:2991-3000. [PMID: 28432463 DOI: 10.1007/s00405-017-4571-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
73 Gomperts BD, Kramer IM, Tatham PE. Growth factors. Signal Transduction. Elsevier; 2002. pp. 225-55. [DOI: 10.1016/b978-012289631-6/50030-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
74 Mateyak MK, Obaya AJ, Sedivy JM. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999;19:4672-83. [PMID: 10373516 DOI: 10.1128/MCB.19.7.4672] [Cited by in Crossref: 210] [Cited by in F6Publishing: 119] [Article Influence: 9.1] [Reference Citation Analysis]
75 Adachi M, Roussel MF, Havenith K, Sherr CJ. Features of Macrophage Differentiation Induced by p19INK4d, a Specific Inhibitor of Cyclin D–Dependent Kinases. Blood 1997;90:126-37. [DOI: 10.1182/blood.v90.1.126.126_126_137] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
76 Gao S, Wang J, Tian S, Luo J. miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16. Int J Oncol 2019;54:1921-32. [PMID: 31081054 DOI: 10.3892/ijo.2019.4783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
77 Fåhraeus R, Fischer P, Krausz E, Lane DP. New approaches to cancer therapies. J Pathol 1999;187:138-46. [DOI: 10.1002/(sici)1096-9896(199901)187:1<138::aid-path252>3.0.co;2-m] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Nargi JL, Ratan RR, Griffin DE. p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E. Neoplasia 1999;1:544-56. [PMID: 10935502 DOI: 10.1038/sj.neo.7900068] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
79 Gerthoffer WT, Schaafsma D, Sharma P, Ghavami S, Halayko AJ. Motility, survival, and proliferation. Compr Physiol 2012;2:255-81. [PMID: 23728975 DOI: 10.1002/cphy.c110018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
80 Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-feldhaus J, Kamb A, Bergman W, Frants RR. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995;10:351-3. [DOI: 10.1038/ng0795-351] [Cited by in Crossref: 205] [Cited by in F6Publishing: 183] [Article Influence: 7.6] [Reference Citation Analysis]
81 Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Mol Cell Biol 2008;28:7236-44. [PMID: 18824542 DOI: 10.1128/MCB.01334-08] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
82 Ryk C, Kumar R, Sanyal S, de Verdier PJ, Hemminki K, Larsson P, Steineck G, Hou SM. Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Lett 2006;241:142-9. [PMID: 16343742 DOI: 10.1016/j.canlet.2005.10.025] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
83 Hermsen MA, Joenje H, Arwert F, Welters MJ, Braakhuis BJ, Bagnay M, Westerveld A, Slater R. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer 1996;15:1-9. [PMID: 8824719 DOI: 10.1002/(SICI)1098-2264(199601)15:1<1::AID-GCC1>3.0.CO;2-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
84 Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000;33:261-74. [PMID: 11063129 DOI: 10.1046/j.1365-2184.2000.00191.x] [Cited by in Crossref: 217] [Cited by in F6Publishing: 208] [Article Influence: 9.9] [Reference Citation Analysis]
85 Fukami J, Anno K, Ueda K, Takahashi T, Ide T. Enhanced expression of cyclin D1 in senescent human fibroblasts. Mech Ageing Dev 1995;81:139-57. [PMID: 8569279 DOI: 10.1016/0047-6374(95)93703-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
86 Wu CM, Huang TH, Xie QD, Wu DS, Xu XH. Construction of pETNF-P16 plasmid and its expression properties in EC9706 cell line induced by X-ray irradiation. World J Gastroenterol 2004; 10(20): 2927-2930 [PMID: 15378766 DOI: 10.3748/wjg.v10.i20.2927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Luo Y, Qu K, Kuai L, Ru Y, Huang K, Yan X, Xing M. Epigenetics in psoriasis: perspective of DNA methylation. Mol Genet Genomics 2021;296:1027-40. [PMID: 34137900 DOI: 10.1007/s00438-021-01804-y] [Reference Citation Analysis]
88 Medema RH, Herrera RE, Lam F, Weinberg RA. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A 1995;92:6289-93. [PMID: 7603984 DOI: 10.1073/pnas.92.14.6289] [Cited by in Crossref: 267] [Cited by in F6Publishing: 290] [Article Influence: 9.9] [Reference Citation Analysis]
89 Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S. Patients with both pancreatic adenocarcinoma and melanoma may harbor germlineCDKN2A mutations. Genes Chromosom Cancer 2000;27:358-61. [DOI: 10.1002/(sici)1098-2264(200004)27:4<358::aid-gcc4>3.0.co;2-o] [Cited by in Crossref: 31] [Article Influence: 1.4] [Reference Citation Analysis]
90 Sayama K, Shirakata Y, Midorikawa K, Hanakawa Y, Hashimoto K. Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence. J Cell Physiol 1999;179:40-4. [DOI: 10.1002/(sici)1097-4652(199904)179:1<40::aid-jcp5>3.0.co;2-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
91 Volgareva GM, Zavalishina LE, Kuznetsova OA, Burova OS. [Reed nevus and cutaneous melanoma in children: an immunohistochemical study]. Arkh Patol 2021;83:30-4. [PMID: 34041893 DOI: 10.17116/patol20218303130] [Reference Citation Analysis]
92 Hall PA, Lane DP. Genetics of growth arrest and cell death: key determinants of tissue homeostasis. Eur J Cancer 1994;30A:2001-12. [PMID: 7734214 DOI: 10.1016/0959-8049(94)00394-k] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
93 Shi Y, Tao T, Liu N, Luan W, Qian J, Li R, Hu Q, Wei Y, Zhang J, You Y. PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop. Oncotarget 2016;7:84623-33. [PMID: 27835866 DOI: 10.18632/oncotarget.13170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
94 Sherr CJ. Parsing Ink4a/Arf. Cell 2001;106:531-4. [DOI: 10.1016/s0092-8674(01)00486-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
95 Robson SC, Ward L, Brown H, Turner H, Hunter E, Pelengaris S, Khan M. Deciphering c-MYC-regulated genes in two distinct tissues. BMC Genomics 2011;12:476. [PMID: 21961992 DOI: 10.1186/1471-2164-12-476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
96 Kastanos E, Hjiantoniou E, Phylactou LA. Restoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes. Biochemical and Biophysical Research Communications 2004;322:930-4. [DOI: 10.1016/j.bbrc.2004.07.203] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
97 Li X, Liu T, Wu TT, Feng Y, Peng SJ, Yin H, Wu YC. SIRT1 Deacetylates TET2 and Promotes Its Ubiquitination Degradation to Achieve Neuroprotection Against Parkinson's Disease. Front Neurol 2021;12:652882. [PMID: 33935952 DOI: 10.3389/fneur.2021.652882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Ip PP, Lim D, Cheung ANY, Oliva E. Immunoexpression of p16 in uterine leiomyomas with infarct-type necrosis: an analysis of 35 cases. Histopathology 2017;71:743-50. [DOI: 10.1111/his.13282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
99 Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999;13:2658-69. [PMID: 10541552 DOI: 10.1101/gad.13.20.2658] [Cited by in Crossref: 545] [Cited by in F6Publishing: 554] [Article Influence: 23.7] [Reference Citation Analysis]
100 Kamb A. Cell-cycle regulators and cancer. Trends Genet. 1995;11:136-140. [PMID: 7732591 DOI: 10.1016/s0168-9525(00)89027-7] [Cited by in Crossref: 188] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
101 Dai CY, Enders GH. p16INK4a can initiate an autonomous senescence program. Oncogene 2000;19:1613-22. [DOI: 10.1038/sj.onc.1203438] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 4.5] [Reference Citation Analysis]
102 Kudo Y, Kitajima S, Ogawa I, Miyauchi M, Takata T. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol. 2005;41:105-116. [PMID: 15695111 DOI: 10.1016/j.oraloncology.2004.05.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
103 Debniak T, Górski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, Gozdecka-Grodecka S, Gronwald J, Kowalska E, Haus O, Grzybowska E, Stawicka M, Swiec M, Urbański K, Niepsuj S, Waśko B, Góźdź S, Wandzel P, Szczylik C, Surdyka D, Rozmiarek A, Zambrano O, Posmyk M, Narod SA, Lubinski J. A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 2005;42:763-5. [PMID: 15879498 DOI: 10.1136/jmg.2005.031476] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
104 Erlandsson R. Molecular Genetics of Renal Cell Carcinoma. Cancer Genetics and Cytogenetics 1998;104:1-18. [DOI: 10.1016/s0165-4608(97)00384-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
105 Patel NH, Bloukh S, Alwohosh E, Alhesa A, Saleh T, Gewirtz DA. Autophagy and senescence in cancer therapy. Adv Cancer Res 2021;150:1-74. [PMID: 33858594 DOI: 10.1016/bs.acr.2021.01.002] [Reference Citation Analysis]
106 Jimenez GS, Khan SH, Stommel JM, Wahl GM. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 1999;18:7656-65. [DOI: 10.1038/sj.onc.1203013] [Cited by in Crossref: 115] [Cited by in F6Publishing: 126] [Article Influence: 5.0] [Reference Citation Analysis]
107 Forget A, Ayrault O, den Besten W, Kuo ML, Sherr CJ, Roussel MF. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d. Cell Cycle 2008;7:3737-46. [PMID: 19029828 DOI: 10.4161/cc.7.23.7187] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
108 Elenitoba-johnson KS, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeld M. Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma. Blood 1998;91:4677-85. [DOI: 10.1182/blood.v91.12.4677] [Cited by in Crossref: 139] [Article Influence: 5.8] [Reference Citation Analysis]
109 Tang KS, Guralnick BJ, Wang WK, Fersht AR, Itzhaki LS. Stability and folding of the tumour suppressor protein p16. J Mol Biol 1999;285:1869-86. [PMID: 9917418 DOI: 10.1006/jmbi.1998.2420] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 4.5] [Reference Citation Analysis]
110 Schröder M, Mathieu U, Dreyling MH, Bohlander SK, Hagemeijer A, Beverloo BH, Olopade OI, Stilgenbauer S, Fischer K, Bentz M, Lichter P, Döhner H. CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia. Br J Haematol 1995;91:865-70. [DOI: 10.1111/j.1365-2141.1995.tb05402.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
111 Yao S, Prelich G. Activation of the Bur1-Bur2 cyclin-dependent kinase complex by Cak1. Mol Cell Biol 2002;22:6750-8. [PMID: 12215532 DOI: 10.1128/MCB.22.19.6750-6758.2002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
112 Zhang B, Xiang S, Yin Y, Gu L, Deng D. C-terminal in Sp1-like artificial zinc-finger proteins plays crucial roles in determining their DNA binding affinity. BMC Biotechnol 2013;13:106. [PMID: 24289163 DOI: 10.1186/1472-6750-13-106] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
113 Yokozaki H, Kuniyasu H, Semba S, Yasui W, Tahara E. Molecular Bases of Human Stomach Carcinogenesis. In: Tahara E, editor. Molecular Pathology of Gastroenterological Cancer. Tokyo: Springer Japan; 1997. pp. 55-70. [DOI: 10.1007/978-4-431-65915-0_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
114 Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999;1:20-6. [PMID: 10559859 DOI: 10.1038/8991] [Cited by in Crossref: 608] [Cited by in F6Publishing: 633] [Article Influence: 26.4] [Reference Citation Analysis]
115 Shimada H, Sakakima H, Tsuchimochi K, Matsuda F, Komiya S, Goldring MB, Ijiri K. Senescence of chondrocytes in aging articular cartilage: GADD45β mediates p21 expression in association with C/EBPβ in senescence-accelerated mice. Pathol Res Pract 2011;207:225-31. [PMID: 21353395 DOI: 10.1016/j.prp.2011.01.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
116 Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y, Yamashita J, Chun T, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Saito T, Sone M, Yamahara K, Kook H, Komeda M, Ueda M, Nakao K. C-Type Natriuretic Peptide Induces Redifferentiation of Vascular Smooth Muscle Cells With Accelerated Reendothelialization. ATVB 2001;21:930-6. [DOI: 10.1161/01.atv.21.6.930] [Cited by in Crossref: 56] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
117 Grønbæk K, de Nully Brown P, Møller M, Nedergaard T, Ralfkiaer E, Møller P, Zeuthen J, Guldberg P. Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma. Leukemia 2000;14:1727-35. [DOI: 10.1038/sj.leu.2401901] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 2.8] [Reference Citation Analysis]
118 Jarrard DF, Bova GS, Isaacs WB. DNA methylation, molecular genetic, and linkage studies in prostate cancer. Prostate 1996;29:36-44. [DOI: 10.1002/(sici)1097-0045(1996)6+<36::aid-pros8>3.0.co;2-i] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
119 González MV, Artímez ML, Rodrigo L, López-Larrea C, Menéndez MJ, Alvarez V, Pérez R, Fresno MF, Pérez MJ, Sampedro A, Coto E. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol 1997;50:212-7. [PMID: 9155671 DOI: 10.1136/jcp.50.3.212] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 2.8] [Reference Citation Analysis]
120 Drissi R, Zindy F, Roussel MF, Cleveland JL. c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells. J Biol Chem. 2001;276:29994-30001. [PMID: 11402027 DOI: 10.1074/jbc.m101899200] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
121 Liu Z, Lin H, Gan Y, Cui C, Zhang B, Gu L, Zhou J, Zhu G, Deng D. P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer. J Cancer 2019;10:1726-33. [PMID: 31205528 DOI: 10.7150/jca.26482] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
122 Li CF, Huang HY, Wu WR, Liang SS, Chen YL, Chen LR, Peng YT, Lee HC, Shiue YL. Clinical aggressiveness of myxofibrosarcomas associates with down-regulation of p12CDK2AP1: prognostic implication of a putative tumor suppressor that induces cell cycle arrest and apoptosis via mitochondrial pathway. Ann Surg Oncol 2014;21 Suppl 4:S711-20. [PMID: 24889487 DOI: 10.1245/s10434-014-3825-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Post SM, Quintás-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene 2010;29:1260-9. [PMID: 19935700 DOI: 10.1038/onc.2009.423] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
124 Epifanova OI, Brooks RF. Negative control of cell proliferation in eukaryotes. Cell Prolif 1994;27:373-94. [DOI: 10.1111/j.1365-2184.1994.tb01470.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
125 Sibin MK, Dhananjaya IB, Narasingarao KV, Harshitha SM, Jeru-Manoj M, Chetan GK. Two gene polymorphisms (rs4977756 and rs11515) in CDKN2A/B and glioma risk in South Indian population. Meta Gene 2016;9:215-8. [PMID: 27617221 DOI: 10.1016/j.mgene.2016.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
126 Liu L, Broaddus RR, Yao JC, Xie S, White JA, Wu TT, Hamilton SR, Rashid A. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol. 2005;18:1632-1640. [PMID: 16258509 DOI: 10.1038/modpathol.3800490] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
127 Gao HJ, Yu LZ, Bai JF, Peng YS, Sun G, Zhao HL, Miu K, Lü XZ, Zhang XY, Zhao ZQ. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H. pylori infection, histological types and staging. World J Gastroenterol 2000; 6(6): 848-854 [PMID: 11819707 DOI: 10.3748/wjg.v6.i6.848] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.6] [Reference Citation Analysis]
128 Güran S, Pak I. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Cancer Genet Cytogenet. 1999;109:108-113. [PMID: 10087941 DOI: 10.1016/s0165-4608(98)00155-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
129 Badawi AF. Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Letters 1996;105:123-38. [DOI: 10.1016/0304-3835(96)04284-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
130 Sawa H, Kamada H, Ohshima TA, Noguchi A, Itoh N, Saruta K, Hara M, Saito I. Exogenous expression of p16INK4a is associated with decrease in telomerase activity. J Neurooncol 1999;42:45-57. [PMID: 10360478 DOI: 10.1023/a:1006176708928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
131 Piao Z, Park C, Lee J, Yang CH, Choi KY, Kim H. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma. Cancer Letters 1998;122:201-7. [DOI: 10.1016/s0304-3835(97)00403-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
132 Lerman DM, Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL; Children's Oncology Group Ewing Sarcoma Biology Committee. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2015;62:759-65. [PMID: 25464386 DOI: 10.1002/pbc.25340] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
133 Dai M, Al-Odaini AA, Fils-Aimé N, Villatoro MA, Guo J, Arakelian A, Rabbani SA, Ali S, Lebrun JJ. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res 2013;15:R49. [PMID: 23786849 DOI: 10.1186/bcr3441] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
134 Wilkin F, Savonet V, Radulescu A, Petermans J, Dumont JE, Maenhaut C. Identification and characterization of novel genes modulated in the thyroid of dogs treated with methimazole and propylthiouracil. J Biol Chem 1996;271:28451-7. [PMID: 8910471 DOI: 10.1074/jbc.271.45.28451] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
135 Volgareva GM, Zavalishina LE, Golovina DA, Andreeva YY, Ermilova VD, Trofimova OB, Kuevda DA, Shipulina OY, Glazunova VA, Cheng S, Pavlova LS, Cheban NL, Matveev VB, Frank GA. Cellular expression of INK4a gene in cells of bladder cancer associated with human papilloma virus-16. Bull Exp Biol Med 2010;149:242-5. [PMID: 21113501 DOI: 10.1007/s10517-010-0917-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
136 Zhu B, Gong Y, Yan G, Wang D, Wang Q, Qiao Y, Hou J, Liu B, Tang C. Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression. FEBS J 2017;284:1868-81. [DOI: 10.1111/febs.14087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
137 Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle 2011;10:2497-503. [PMID: 21775818 DOI: 10.4161/cc.10.15.16776] [Cited by in Crossref: 156] [Cited by in F6Publishing: 149] [Article Influence: 14.2] [Reference Citation Analysis]
138 Liao Y, Feng Y, Shen J, Hornicek FJ, Duan Z. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma. Cancer Metastasis Rev 2016;35:151-63. [PMID: 26669603 DOI: 10.1007/s10555-015-9601-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
139 Kritsilis M, V Rizou S, Koutsoudaki PN, Evangelou K, Gorgoulis VG, Papadopoulos D. Ageing, Cellular Senescence and Neurodegenerative Disease. Int J Mol Sci. 2018;19. [PMID: 30261683 DOI: 10.3390/ijms19102937] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 22.0] [Reference Citation Analysis]
140 Kato JY, Matsuoka M, Strom DK, Sherr CJ. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol 1994;14:2713-21. [PMID: 8139570 DOI: 10.1128/mcb.14.4.2713-2721.1994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 75] [Article Influence: 0.1] [Reference Citation Analysis]
141 Sherr CJ, Sicinski P. The D-Type Cyclins: A Historical Perspective. In: Hinds PW, Brown NE, editors. D-type Cyclins and Cancer. Cham: Springer International Publishing; 2018. pp. 1-26. [DOI: 10.1007/978-3-319-64451-6_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
142 Kiwerska K, Rydzanicz M, Kram A, Pastok M, Antkowiak A, Domagała W, Szyfter K. Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients. Mol Biol Rep 2010;37:325-32. [DOI: 10.1007/s11033-009-9731-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
143 Nakasu S, Nakajima M, Handa J. Anomalous p27kip1 expression in a subset of malignant gliomas. Brain Tumor Pathol 1999;16:17-21. [DOI: 10.1007/bf02478897] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
144 Zhao GH, Li TC, Shi LH, Xia YB, Lu LM, Huang WB, Sun HL, Zhang YS. Relationship between inactivation of p16 gene and gastric carcinoma. World J Gastroenterol 2003; 9(5): 905-909 [PMID: 12717828 DOI: 10.3748/wjg.v9.i5.905] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
145 Fung N, Faraji F, Kang H, Fakhry C. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma. Cancer Metastasis Rev 2017;36:449-61. [PMID: 28812214 DOI: 10.1007/s10555-017-9686-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
146 Bhagat R, Kumar SS, Vaderhobli S, Premalata CS, Pallavi VR, Ramesh G, Krishnamoorthy L. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma. Tumour Biol 2014;35:9069-78. [PMID: 24913706 DOI: 10.1007/s13277-014-2136-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
147 Ferrando AA, Balbín M, Pendás AM, Vizoso F, Velasco G, López-Otín C. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas. Hum Genet. 1996;97:91-94. [PMID: 8557269 DOI: 10.1007/BF00218840] [Cited by in Crossref: 51] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
148 Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 1996;85:733-744. [PMID: 8646781 DOI: 10.1016/S0092-8674(00)81239-8] [Cited by in Crossref: 1068] [Cited by in F6Publishing: 423] [Article Influence: 41.1] [Reference Citation Analysis]
149 Skolnick M, Cannon-albright L, Kamb A. Genetic predisposition to melanoma. European Journal of Cancer 1994;30:1991-5. [DOI: 10.1016/0959-8049(94)00392-i] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
150 Aird KM, Zhang R. Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett 2015;356:204-10. [PMID: 24486217 DOI: 10.1016/j.canlet.2014.01.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 7.8] [Reference Citation Analysis]
151 Tsuji K, Mizumoto K, Sudo H, Kouyama K, Ogata E, Matsuoka M. p53-independent apoptosis is induced by the p19ARF tumor suppressor. Biochemical and Biophysical Research Communications 2002;295:621-9. [DOI: 10.1016/s0006-291x(02)00723-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
152 Rabbani F, Cordon-Cardo C. Mutation of cell cycle regulators and their impact on superficial bladder cancer. Urol Clin North Am. 2000;27:83-102, ix. [PMID: 10696248 DOI: 10.1016/s0094-0143(05)70237-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
153 Martin A, Baran-Marzak F, El Mansouri S, Legendre C, Leblond V, Charlotte F, Davi F, Canioni D, Raphaël M. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders. Am J Pathol 2000;156:1573-9. [PMID: 10793069 DOI: 10.1016/S0002-9440(10)65029-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
154 Pinyol M, Hernandez L, Cazorla M, Balbı́n M, Jares P, Fernandez PL, Montserrat E, Cardesa A, Lopez-otı́n C, Campo E. Deletions and Loss of Expression of P16INK4a and P21Waf1 Genes Are Associated With Aggressive Variants of Mantle Cell Lymphomas. Blood 1997;89:272-80. [DOI: 10.1182/blood.v89.1.272] [Cited by in Crossref: 171] [Article Influence: 6.8] [Reference Citation Analysis]
155 Pinyol M, Hernandez L, Cazorla M, Balbı́n M, Jares P, Fernandez PL, Montserrat E, Cardesa A, Lopez-otı́n C, Campo E. Deletions and Loss of Expression of P16INK4a and P21Waf1 Genes Are Associated With Aggressive Variants of Mantle Cell Lymphomas. Blood 1997;89:272-80. [DOI: 10.1182/blood.v89.1.272.272_272_280] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
156 Jackson MW, Lindstrom MS, Berberich SJ. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation. J Biol Chem 2001;276:25336-41. [PMID: 11297540 DOI: 10.1074/jbc.M010685200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
157 zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78. [PMID: 8876633 DOI: 10.1016/0304-419x(96)00020-0] [Cited by in Crossref: 161] [Cited by in F6Publishing: 352] [Article Influence: 6.2] [Reference Citation Analysis]
158 Satra M, Vamvakopoulou DN, Sioutopoulou DO, Kollia P, Kiritsaka A, Sotiriou S, Antonakopoulos G, Alexandris E, Costantoulakis P, Vamvakopoulos NC. Sequence-based genotyping HPV L1 DNA and RNA transcripts in clinical specimens. Pathology - Research and Practice 2009;205:863-9. [DOI: 10.1016/j.prp.2009.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
159 Lelliott EJ, McArthur GA, Oliaro J, Sheppard KE. Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma. Front Immunol 2021;12:661737. [PMID: 34025662 DOI: 10.3389/fimmu.2021.661737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Kawamata N, Seriu T, Koeffler HP, Bartram CR. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas. Cancer 1996;77:570-5. [DOI: 10.1002/(sici)1097-0142(19960201)77:3<570::aid-cncr21>3.0.co;2-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
161 Yuan K, Wang X, Dong H, Min W, Hao H, Yang P. Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs. Acta Pharm Sin B 2021;11:30-54. [PMID: 33532179 DOI: 10.1016/j.apsb.2020.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
162 Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer. 1999;80:79-86. [PMID: 10389982 DOI: 10.1038/sj.bjc.6690505] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
163 Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002;52:375-383. [PMID: 12100520 DOI: 10.1046/j.1440-1827.2002.01359.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 4.0] [Reference Citation Analysis]
164 Walker GJ, Flores JF, Glendening JM, Lin A(, Markl IDC, Fountain JW. Virtually 100% of melanoma cell lines harbor alterations at the DNA level withinCDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosom Cancer 1998;22:157-63. [DOI: 10.1002/(sici)1098-2264(199806)22:2<157::aid-gcc11>3.0.co;2-n] [Cited by in Crossref: 88] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
165 Rollins LA, Leone-Kabler S, O'Sullivan MG, Miller MS. Role of tumor suppressor genes in transplacental lung carcinogenesis. Mol Carcinog 1998;21:177-84. [PMID: 9537649 DOI: 10.1002/(sici)1098-2744(199803)21:3<177::aid-mc5>3.0.co;2-j] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Shiraishi T, Tabuchi K. Genetic alterations of human brain tumors as molecular prognostic factors. Neuropathology 2003;23:95-108. [DOI: 10.1046/j.1440-1789.2003.00477.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
167 Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci U S A 1996;93:15215-20. [PMID: 8986790 DOI: 10.1073/pnas.93.26.15215] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 3.2] [Reference Citation Analysis]
168 Kuenzler P, Kuchen S, ?iho?kov� V, Michel BA, Gay RE, Neidhart M, Gay S, Seemayer CA. Induction of p16 at sites of cartilage invasion in the SCID mouse coimplantation model of rheumatoid arthritis. Arthritis & Rheumatism 2003;48:2069-73. [DOI: 10.1002/art.11045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
169 De Azevedo WF Jr, Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E, Kim SH. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci U S A 1996;93:2735-40. [PMID: 8610110 DOI: 10.1073/pnas.93.7.2735] [Cited by in Crossref: 321] [Cited by in F6Publishing: 307] [Article Influence: 12.3] [Reference Citation Analysis]
170 Zhao N, Zeng L, Liu Y, Han D, Liu H, Xu J, Jiang Y, Li C, Cai T, Feng H, Wang Y. DLX3 promotes bone marrow mesenchymal stem cell proliferation through H19/miR-675 axis. Clin Sci (Lond) 2017;131:2721-35. [PMID: 28963438 DOI: 10.1042/CS20171231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
171 Lu ZM, Zhou J, Wang X, Guan Z, Bai H, Liu ZJ, Su N, Pan K, Ji J, Deng D. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. PLoS One. 2012;7:e35928. [PMID: 22558275 DOI: 10.1371/journal.pone.0035928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
172 Doherty JR, Nilsson LM, Kuliyev E, Zhu H, Matthew R, Cleveland JL, Mead PE, Roussel MF. Embryonic Expression and Function of the Xenopus Ink4d Cyclin D-Dependent Kinase Inhibitor. Cell Dev Biol 2014;3:133. [PMID: 25309971 DOI: 10.4172/2168-9296.1000133] [Reference Citation Analysis]
173 Tigan AS, Bellutti F, Kollmann K, Tebb G, Sexl V. CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation. Oncogene 2016;35:3083-91. [PMID: 26500059 DOI: 10.1038/onc.2015.407] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 10.9] [Reference Citation Analysis]
174 Indovina P, Acquaviva A, De Falco G, Rizzo V, Onnis A, Luzzi A, Giorgi F, Hadjistilianou T, Toti P, Tomei V, Pentimalli F, Carugi A, Giordano A. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol 2010;223:143-50. [PMID: 20039270 DOI: 10.1002/jcp.22019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
175 Deeds L, Teodorescu S, Chu M, Yu Q, Chen CY. A p53-independent G1 cell cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms. J Biol Chem. 2003;278:39782-39793. [PMID: 12896972 DOI: 10.1074/jbc.m306854200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
176 Schmid RM. Genetic basis of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2002;16:421-433. [PMID: 12079267 DOI: 10.1053/bega.2002.0316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
177 Zhang L, Yamane T, Satoh E, Amagasaki K, Kawataki T, Asahara T, Furuya K, Nukui H, Naganuma H. Establishment and partial characterization of five malignant glioma cell lines. Neuropathology 2005;25:136-43. [PMID: 15875906 DOI: 10.1111/j.1440-1789.2005.00601.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
178 Burassakarn A, Pientong C, Sunthamala N, Chuerduangphui J, Vatanasapt P, Patarapadungkit N, Kongyingyoes B, Ekalaksananan T. Aberrant gene promoter methylation of E-cadherin, p16 INK4a , p14 ARF , and MGMT in Epstein–Barr virus-associated oral squamous cell carcinomas. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-0983-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
179 Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741-1748. [PMID: 9846965 DOI: 10.1016/s0002-9440(10)65689-1] [Cited by in Crossref: 392] [Cited by in F6Publishing: 118] [Article Influence: 16.3] [Reference Citation Analysis]
180 Morsli S, Doherty GJ, Muñoz-Espín D. Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells. Mech Ageing Dev 2022;202:111618. [PMID: 34990647 DOI: 10.1016/j.mad.2021.111618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Cudré-mauroux C, Occhiodoro T, König S, Salmon P, Bernheim L, Trono D. Lentivector-Mediated Transfer of Bmi-1 and Telomerase in Muscle Satellite Cells Yields a Duchenne Myoblast Cell Line with Long-Term Genotypic and Phenotypic Stability. Human Gene Therapy 2003;14:1525-33. [DOI: 10.1089/104303403322495034] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 3.7] [Reference Citation Analysis]
182 Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW, Aaronson SA. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 2002;21:2180-2188. [PMID: 11980715 DOI: 10.1093/emboj/21.9.2180] [Cited by in Crossref: 219] [Cited by in F6Publishing: 203] [Article Influence: 11.0] [Reference Citation Analysis]
183 Lossos IS, Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Seminars in Cancer Biology 2003;13:191-202. [DOI: 10.1016/s1044-579x(03)00015-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
184 Clément G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J Pathol 2006;208:100-7. [PMID: 16278815 DOI: 10.1002/path.1884] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 5.2] [Reference Citation Analysis]
185 DeLeon TT, Ahn DH, Bogenberger JM, Anastasiadis PZ, Arora M, Ramanathan RK, Aqel BA, Vasmatzis G, Truty MJ, Oklu R, Bekaii-Saab TS, Borad MJ. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma. Future Oncol 2018;14:553-66. [PMID: 29460642 DOI: 10.2217/fon-2017-0451] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
186 Gartel AL, Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res. 1999;246:280-289. [PMID: 9925742 DOI: 10.1006/excr.1998.4319] [Cited by in Crossref: 478] [Cited by in F6Publishing: 464] [Article Influence: 20.8] [Reference Citation Analysis]
187 Konishi N, Cho N, Yamamoto K, Hiasa Y. Genetic changes in prostate cancer. Pathology International 1997;47:735-47. [DOI: 10.1111/j.1440-1827.1997.tb04451.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
188 Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007;130:223-33. [PMID: 17662938 DOI: 10.1016/j.cell.2007.07.003] [Cited by in Crossref: 1090] [Cited by in F6Publishing: 1008] [Article Influence: 72.7] [Reference Citation Analysis]
189 Huang J, El-Gamil M, Dudley ME, Li YF, Rosenberg SA, Robbins PF. T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product. J Immunol 2004;172:6057-64. [PMID: 15128789 DOI: 10.4049/jimmunol.172.10.6057] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 4.5] [Reference Citation Analysis]
190 Fargnoli MC, Chimenti S, Keller G, Soyer HP, Dal Pozzo V, Höfler H, Peris K. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. J Invest Dermatol 1998;111:1202-6. [PMID: 9856841 DOI: 10.1046/j.1523-1747.1998.00412.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
191 Kohno T, Yamada Y, Tawara M, Takasaki Y, Kamihira S, Tomonaga M, Matsuyama T. Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma. Leuk Res 2007;31:1625-32. [PMID: 18246599 DOI: 10.1016/j.leukres.2006.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
192 Lin YW, Chen CH, Huang GT, Lee PH, Wang JT, Chen DS, Lu FJ, Sheu JC. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Eur J Cancer 1998;34:1789-95. [PMID: 9893670 DOI: 10.1016/s0959-8049(98)00189-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
193 Nilsson K, Svensson S, Landberg G. Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod Pathol. 2004;17:1464-1474. [PMID: 15257310 DOI: 10.1038/modpathol.3800220] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
194 Hayes MJ, Koundouris A, Gruis N, Bergman W, Peters GG, Sinclair AJ. p16(INK4A)-independence of Epstein-Barr virus-induced cell proliferation and virus latency. J Gen Virol 2004;85:1381-6. [PMID: 15166419 DOI: 10.1099/vir.0.79831-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
195 Ghazizadeh M, Jin E, Shimizu H, Fujiwara M, Arai S, Ohaki Y, Takemura T, Kawanami O. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas. Respiration 2005;72:68-73. [PMID: 15753637 DOI: 10.1159/000083403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
196 Cheng L, Rossi F, Fang W, Mori T, Cobrinik D. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells. J Biol Chem 2000;275:30317-25. [PMID: 10906146 DOI: 10.1074/jbc.M005707200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
197 Delmonico L, Silva Magalhães Costa MA, Gomes RJ, De Oliveira Vieira P, Da Silva ABP, Fournier MV, Scherrer LR, De Azevedo CM, Ornellas MHF, Alves G. Methylation profiling in promoter sequences of ATM and CDKN2A (p14ARF/p16INK4a ) genes in blood and cfDNA from women with impalpable breast lesions. Oncol Lett 2020;19:3003-10. [PMID: 32218857 DOI: 10.3892/ol.2020.11382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-196. [PMID: 9338076 DOI: 10.1016/s0065-230x(08)60702-2] [Cited by in Crossref: 1168] [Cited by in F6Publishing: 12] [Article Influence: 46.7] [Reference Citation Analysis]
199 Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S. Oxidative DNA damage induced by photodegradation products of 3(')-azido-3(')-deoxythymidine. Arch Biochem Biophys 2003;416:155-63. [PMID: 12893292 DOI: 10.1016/s0003-9861(03)00316-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
200 Singh CR, Kathiresan K. Molecular understanding of lung cancers-A review. Asian Pac J Trop Biomed 2014;4:S35-41. [PMID: 25183110 DOI: 10.12980/APJTB.4.2014C597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
201 Potter ML, Hill WD, Isales CM, Hamrick MW, Fulzele S. MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells. Bone 2021;142:115679. [PMID: 33022453 DOI: 10.1016/j.bone.2020.115679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
202 Ito N, Sawa H, Nagane M, Noguchi A, Hara M, Saito I. Inhibitory Effects of Sodium Butyrate on Proliferation and Invasiveness of Human Glioma Cells: . Neurosurgery 2001;49:430-7. [DOI: 10.1227/00006123-200108000-00031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
203 Yamakoshi K, Katano S, Iida M, Kimura H, Okuma A, Ikemoto-Uezumi M, Ohtani N, Hara E, Maruyama M. Dysregulation of the Bmi-1/p16(Ink⁴a) pathway provokes an aging-associated decline of submandibular gland function. Aging Cell 2015;14:616-24. [PMID: 25832744 DOI: 10.1111/acel.12337] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
204 Gartel AL, Tyner AL. The growth-regulatory role of p21 (WAF1/CIP1). Prog Mol Subcell Biol. 1998;20:43-71. [PMID: 9928526 DOI: 10.1007/978-3-642-72149-6_4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
205 Báez A. Genetic and environmental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008;26:174-200. [PMID: 18569329 DOI: 10.1080/10590500802129431] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
206 Poolman RA, Gilchrist R, Brooks G. Cell cycle profiles and expressions of p21CIP1 and p27KIP1 during myocyte development. International Journal of Cardiology 1998;67:133-42. [DOI: 10.1016/s0167-5273(98)00320-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
207 Tanaka Y, Zhang SJ, Terasaki H, Koga H, Endo S, Usui H, Washiyama K, Kumanishi T, Uematsu Y, Itakura T. Frequent and variable abnormalities in p14 tumor suppressor gene in glioma cell lines. Brain Tumor Pathol 2008;25:9-17. [PMID: 18415661 DOI: 10.1007/s10014-007-0226-0] [Reference Citation Analysis]
208 Zhang X, Zhou D, Strakovsky R, Zhang Y, Pan YX. Hepatic cellular senescence pathway genes are induced through histone modifications in a diet-induced obese rat model. Am J Physiol Gastrointest Liver Physiol 2012;302:G558-64. [PMID: 22194422 DOI: 10.1152/ajpgi.00032.2011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
209 Ma HB, Hu HT, Di ZL, Wang ZR, Shi JS, Wang XJ, Li Y. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol 2005; 11(5): 744-747 [PMID: 15655836 DOI: 10.3748/wjg.v11.i5.744] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
210 Pollock PM, Pearson JV, Hayward NK. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer 1996;15:77-88. [PMID: 8834170 DOI: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
211 Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, Tomita N, Shimano T, Shiozaki H, Monden M. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 1995;71:1231-6. [PMID: 7779716 DOI: 10.1038/bjc.1995.238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.2] [Reference Citation Analysis]
212 Liu F, Lee WH. CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression. Mol Cell Biol 2006;26:3124-34. [PMID: 16581787 DOI: 10.1128/MCB.26.8.3124-3134.2006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
213 Wang F, Qi X, Li Z, Jin S, Xie Y, Zhong H. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Cancer Manag Res 2019;11:3813-28. [PMID: 31118799 DOI: 10.2147/CMAR.S197673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
214 Kawakami Y, Yamaguchi E, Munakata M, Dosaka-Akita H, Furuya K. Genetic factors in lung disease. Part II: Lung cancer and angiotensin converting enzyme gene. Respirology 1997;2:81-90. [PMID: 9441131 DOI: 10.1111/j.1440-1843.1997.tb00059.x] [Reference Citation Analysis]
215 Tan S, Sun C, Wei X, Li Y, Wu Y, Yan Z, Feng F, Wang J, Wu Y. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood. Exp Lung Res. 2013;39:182-190. [PMID: 23614702 DOI: 10.3109/01902148.2013.790096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
216 Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998;82:396-403. [PMID: 9486668 DOI: 10.1161/01.res.82.3.396] [Cited by in Crossref: 166] [Cited by in F6Publishing: 35] [Article Influence: 6.9] [Reference Citation Analysis]
217 Qureshi MA, Jan N, Dar NA, Hussain M, Andrabi KI. A novel p16 INK4A mutation associated with esophageal squamous cell carcinoma in a high risk population. Biomarkers 2012;17:552-6. [DOI: 10.3109/1354750x.2012.699556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
218 Fargnoli MC, Argenziano G, Zalaudek I, Peris K. High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Review of Anticancer Therapy 2014;6:657-70. [DOI: 10.1586/14737140.6.5.657] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
219 Wang X, Chen Y, Han QB, Chan CY, Wang H, Liu Z, Cheng CH, Yew DT, Lin MC, He ML. Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics. 2009;9:242-253. [PMID: 19086098 DOI: 10.1002/pmic.200800155] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
220 Bartsch DK, Sina-Frey M, Lang S, Wild A, Gerdes B, Barth P, Kress R, Grützmann R, Colombo-Benkmann M, Ziegler A, Hahn SA, Rothmund M, Rieder H. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg 2002;236:730-7. [PMID: 12454511 DOI: 10.1097/00000658-200212000-00005] [Cited by in Crossref: 118] [Cited by in F6Publishing: 102] [Article Influence: 6.2] [Reference Citation Analysis]
221 Du W, Liu Z, Zhu W, Li T, Zhu Z, Wei L, Song J, Pei D. CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16INK4a. Cancer Biol Med 2019;16:514-29. [PMID: 31565481 DOI: 10.20892/j.issn.2095-3941.2018.0410] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
222 Beumer TL, Kiyokawa H, Roepers-Gajadien HL, van den Bos LA, Lock TM, Gademan IS, Rutgers DH, Koff A, de Rooij DG. Regulatory role of p27kip1 in the mouse and human testis. Endocrinology 1999;140:1834-40. [PMID: 10098522 DOI: 10.1210/endo.140.4.6638] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 2.4] [Reference Citation Analysis]
223 Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97:1172-1179. [PMID: 11222358 DOI: 10.1182/blood.V97.5.1172] [Cited by in Crossref: 295] [Cited by in F6Publishing: 146] [Article Influence: 14.0] [Reference Citation Analysis]
224 Rush EB, Abouezzi Z, Borgen PI, Anelli A. Analysis of MTS1/CDK4 in female breast carcinomas. Cancer Letters 1995;89:223-6. [DOI: 10.1016/0304-3835(95)03691-o] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
225 Pei X, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 2005;24:2787-95. [DOI: 10.1038/sj.onc.1208611] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 6.2] [Reference Citation Analysis]
226 Wang Y, Uhara H, Yamazaki Y, Nikaido T, Saida T. Immunohistochemical detection of CDK4 and 9 16 INK4 proteins in cutaneous malignant melanoma. British Journal of Dermatology 1996;134:269-75. [DOI: 10.1111/j.1365-2133.1996.tb07612.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
227 Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 1999;91:2087-95. [PMID: 10601379 DOI: 10.1093/jnci/91.24.2087] [Cited by in Crossref: 143] [Cited by in F6Publishing: 126] [Article Influence: 6.2] [Reference Citation Analysis]
228 Luh FY, Archer SJ, Domaille PJ, Smith BO, Owen D, Brotherton DH, Raine ARC, Xu X, Brizuela L, Brenner SL, Laue ED. Structure of the cyclin-dependent kinase inhibitor p19Ink4d. Nature 1997;389:999-1003. [DOI: 10.1038/40202] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 3.1] [Reference Citation Analysis]
229 Ausserlechner MJ, Obexer P, Wiegers GJ, Hartmann BL, Geley S, Kofler R. The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels. J Biol Chem 2001;276:10984-9. [PMID: 11278393 DOI: 10.1074/jbc.M008188200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
230 Węsierska-gądek J, Maurer M, Zulehner N, Komina O. Whether to target single or multiple CDKs for therapy? That is the question. J Cell Physiol 2011;226:341-9. [DOI: 10.1002/jcp.22426] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
231 Estanyol JM, Jaumot M, Casanovas O, Rodriguez-vilarrupla A, Agell N, Bachs O. The Protein SET Regulates the Inhibitory Effect of p21Cip1 on Cyclin E-Cyclin-dependent Kinase 2 Activity. Journal of Biological Chemistry 1999;274:33161-5. [DOI: 10.1074/jbc.274.46.33161] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 2.8] [Reference Citation Analysis]
232 Hang S, Tiwari AF, Ngan HY, Yip YL, Cheung AL, Tsao SW, Deng W. Extremely stringent activation of p16INK4a prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expression. Oncotarget 2016;7:45656-70. [PMID: 27344169 DOI: 10.18632/oncotarget.10120] [Reference Citation Analysis]
233 Gao X, Honn KV. Recessive oncogenes: current status. Pathol Oncol Res 1995;1:7-22. [PMID: 11173562 DOI: 10.1007/BF02893578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
234 Shan Z, Shakoori A, Bodaghi S, Goldsmith P, Jin J, Wiest JS. TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLoS One 2013;8:e66114. [PMID: 23776618 DOI: 10.1371/journal.pone.0066114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
235 Kai M, Arakawa H, Sugimoto Y, Murata Y, Ogawa M, Nakamura Y. Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas. Jpn J Cancer Res 1995;86:249-51. [PMID: 7744694 DOI: 10.1111/j.1349-7006.1995.tb03047.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
236 Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M, Sakai T. Indole-3-carbinol activates the cyclin-dependent kinase inhibitor p15 INK4b gene. FEBS Letters 2004;576:137-40. [DOI: 10.1016/j.febslet.2004.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
237 Otieno S, Grace CR, Kriwacki RW. The role of the LH subdomain in the function of the Cip/Kip cyclin-dependent kinase regulators. Biophys J 2011;100:2486-94. [PMID: 21575583 DOI: 10.1016/j.bpj.2011.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
238 Poirier F, Pontet M, Labas V, Caër JL, Sghiouar-imam N, Raphaël M, Caron M, Joubert-caron R. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: Protein pattern changes following treatment with 5′-azycytidine. Electrophoresis 2001;22:1867-78. [DOI: 10.1002/1522-2683(200105)22:9<1867::aid-elps1867>3.0.co;2-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
239 Al-Ansari MM, Hendrayani SF, Shehata AI, Aboussekhra A. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts. Oncogene 2013;32:2356-64. [PMID: 22751126 DOI: 10.1038/onc.2012.270] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
240 Zong H, Li Z, Liu L, Hong Y, Yun X, Jiang J, Chi Y, Wang H, Shen X, Hu Y, Niu Z, Gu J. Cyclin-dependent kinase 11 p58 interacts with HBO1 and enhances its histone acetyltransferase activity. FEBS Letters 2005;579:3579-88. [DOI: 10.1016/j.febslet.2005.05.039] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
241 Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996;85:27-37. [PMID: 8620534 DOI: 10.1016/s0092-8674(00)81079-x] [Cited by in Crossref: 1087] [Cited by in F6Publishing: 452] [Article Influence: 41.8] [Reference Citation Analysis]
242 Badenas C, Aguilera P, Puig-Butillé JA, Carrera C, Malvehy J, Puig S. Genetic counseling in melanoma. Dermatol Ther 2012;25:397-402. [PMID: 23046018 DOI: 10.1111/j.1529-8019.2012.01499.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
243 Arima Y, Hayashi N, Hayashi H, Sasaki M, Kai K, Sugihara E, Abe E, Yoshida A, Mikami S, Nakamura S, Saya H. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. Int J Cancer 2012;130:2568-79. [DOI: 10.1002/ijc.26271] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
244 Schoos A, Knab VM, Gabriel C, Tripolt S, Wagner DA, Bauder B, Url A, Fux DA. In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours. Vet Comp Oncol 2019;17:507-21. [PMID: 31207004 DOI: 10.1111/vco.12514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
245 Ikegami T, Uehara T, Deng Z, Kondo S, Maeda H, Kiyuna A, Agena S, Hirakawa H, Yamashita Y, Ganaha A, Suzuki M. Detection of human papillomavirus in branchial cleft cysts. Oncol Lett 2018;16:1571-8. [PMID: 30008839 DOI: 10.3892/ol.2018.8827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
246 Cantarutti AL, Fernandes LP, Saldanha MV, Marques AE, Vianna LM, de Melo NS, Guerra EN. Evaluation of immunohistochemical expression of p16 and presence of human papillomavirus in oral and oropharyngeal carcinoma. J Craniofac Surg 2014;25:210-4. [PMID: 24406580 DOI: 10.1097/SCS.0000000000000424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
247 Murphy JA, Barrantes-reynolds R, Kocherlakota R, Bond JP, Greenblatt MS. The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease association. Hum Mutat 2004;24:296-304. [DOI: 10.1002/humu.20083] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
248 Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1. Exp Cell Res 1999;253:503-10. [PMID: 10585273 DOI: 10.1006/excr.1999.4698] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
249 Pal A, Potjer TP, Thomsen SK, Ng HJ, Barrett A, Scharfmann R, James TJ, Bishop DT, Karpe F, Godsland IF, Vasen HF, Newton-Bishop J, Pijl H, McCarthy MI, Gloyn AL. Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans. Diabetes 2016;65:527-33. [PMID: 26542317 DOI: 10.2337/db15-0602] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
250 Savickiene J, Treigyte G, Jonusiene V, Bruzaite R, Borutinskaite VV, Navakauskiene R. Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells. Mol Cell Biochem 2012;359:245-61. [PMID: 21842375 DOI: 10.1007/s11010-011-1019-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
251 Wang C, Li Z, Fu M, Bouras T, Pestell RG. Signal Transduction Mediated by Cyclin D1: from Mitogens to Cell Proliferation: A Molecular Target with Therapeutic Potential. In: Kumar R, editor. Molecular Targeting and Signal Transduction. Boston: Kluwer Academic Publishers; 2004. pp. 217-37. [DOI: 10.1007/1-4020-7847-1_11] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Reference Citation Analysis]
252 Pipkin J, Hinson W, James S, Lyn-cook L, Duffy P, Feuers R, Shaddock J, Aly K, Hart R, Casciano D. p53 synthesis and phosphorylation in the aging diet-restricted rat following retinoic acid administration. Mechanisms of Ageing and Development 1997;97:15-34. [DOI: 10.1016/s0047-6374(97)01896-4] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
253 Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330. [PMID: 7736585 DOI: 10.1016/0092-8674(95)90385-2] [Cited by in Crossref: 3243] [Cited by in F6Publishing: 3174] [Article Influence: 120.1] [Reference Citation Analysis]
254 Howe JR, Conlon KC. The molecular genetics of pancreatic cancer. Surg Oncol. 1997;6:1-18. [PMID: 9364657 DOI: 10.1016/S0960-7404(97)00001-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
255 Müllner EW, Dolznig H, Beug H. Cell cycle regulation and erythroid differentiation. Curr Top Microbiol Immunol 1996;212:175-94. [PMID: 8934819 DOI: 10.1007/978-3-642-80057-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
256 Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int 2009;76:604-13. [PMID: 19536080 DOI: 10.1038/ki.2009.224] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 10.5] [Reference Citation Analysis]
257 Sheaff RJ, Roberts JM. Regulation of G1 Phase. In: Pagano M, editor. Cell Cycle Control. Berlin: Springer Berlin Heidelberg; 1998. pp. 1-34. [DOI: 10.1007/978-3-540-69686-5_1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
258 LaPak KM, Burd CE. The molecular balancing act of p16(INK4a) in cancer and aging. Mol Cancer Res 2014;12:167-83. [PMID: 24136988 DOI: 10.1158/1541-7786.MCR-13-0350] [Cited by in Crossref: 126] [Cited by in F6Publishing: 72] [Article Influence: 14.0] [Reference Citation Analysis]
259 Volm M, Koomägi R, Stammler G, Rittgen W, Zintl F, Sauerbrey A. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRb, p16INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer 1997;74:508-12. [DOI: 10.1002/(sici)1097-0215(19971021)74:5<508::aid-ijc5>3.0.co;2-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
260 Piepkorn M. Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors. Journal of the American Academy of Dermatology 2000;42:705-26. [DOI: 10.1067/mjd.2000.104687] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
261 Xirodimas DP, Chisholm J, Desterro JM, Lane DP, Hay RT. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett 2002;528:207-11. [PMID: 12297306 DOI: 10.1016/s0014-5793(02)03310-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
262 Udayakumar D, Tsao H. Melanoma genetics: an update on risk-associated genes. Hematol Oncol Clin North Am 2009;23:415-29, vii. [PMID: 19464594 DOI: 10.1016/j.hoc.2009.03.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
263 Yasui W, Kudo Y, Semba S, Yokozaki H, Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res. 1997;88:625-629. [PMID: 9310133 DOI: 10.1111/j.1349-7006.1997.tb00428.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 4.0] [Reference Citation Analysis]
264 Liu YT, Carson DA. A novel approach for determining cancer genomic breakpoints in the presence of normal DNA. PLoS One 2007;2:e380. [PMID: 17440616 DOI: 10.1371/journal.pone.0000380] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
265 Zhang WW. Antisense oncogene and tumor suppressor gene therapy of cancer. J Mol Med (Berl) 1996;74:191-204. [PMID: 8740650 DOI: 10.1007/BF00204749] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
266 Cao D, Begum S, Ali SZ, Westra WH. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Human Pathology 2010;41:535-9. [DOI: 10.1016/j.humpath.2009.09.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
267 Kapust RB, Waugh DS. Controlled intracellular processing of fusion proteins by TEV protease. Protein Expr Purif 2000;19:312-8. [PMID: 10873547 DOI: 10.1006/prep.2000.1251] [Cited by in Crossref: 141] [Cited by in F6Publishing: 137] [Article Influence: 6.4] [Reference Citation Analysis]
268 Dannenberg JH, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000;14:3051-64. [PMID: 11114893 DOI: 10.1101/gad.847700] [Cited by in Crossref: 283] [Cited by in F6Publishing: 300] [Article Influence: 13.5] [Reference Citation Analysis]
269 Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999;18:1571-83. [PMID: 10075928 DOI: 10.1093/emboj/18.6.1571] [Cited by in Crossref: 787] [Cited by in F6Publishing: 760] [Article Influence: 34.2] [Reference Citation Analysis]
270 Gomi A, Sakai R, Ogawa S, Shinoda S, Hirai H, Masuzawa T. Frequent loss of the cyclin-dependent kinase-4 inhibitor gene in human gliomas. Jpn J Cancer Res 1995;86:342-6. [PMID: 7775255 DOI: 10.1111/j.1349-7006.1995.tb03062.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
271 Sakata K. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med 1996;25:302-7. [DOI: 10.1111/j.1600-0714.1996.tb00266.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
272 Tlsty TD, Briot A, Gualberto A, Hall I, Hess S, Hixon M, Kuppuswamy D, Romanov S, Sage M, White A. Genomic instability and cancer. Mutat Res 1995;337:1-7. [PMID: 7596354 DOI: 10.1016/0921-8777(95)00016-d] [Cited by in Crossref: 63] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
273 Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, A Al-Hussein K, Aboussekhra A. The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 2004;23:201-12. [PMID: 14712225 DOI: 10.1038/sj.onc.1206927] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
274 Orjuela M, Orlow I, Dudas M, Ponce-castañeda M, Ridaura C, Leal C, Salazar A, Abramson D, Gerald W, Cordon-cardo C. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma. Human Pathology 2001;32:537-44. [DOI: 10.1053/hupa.2001.24325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
275 Simon M, Simon C, Köster G, Hans VH, Schramm J. Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression. J Neurooncol 2002;60:1-12. [PMID: 12416540 DOI: 10.1023/a:1020226130478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
276 Ikuta M, Kamata K, Fukasawa K, Honma T, Machida T, Hirai H, Suzuki-Takahashi I, Hayama T, Nishimura S. Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein. J Biol Chem 2001;276:27548-54. [PMID: 11335721 DOI: 10.1074/jbc.M102060200] [Cited by in Crossref: 69] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
277 Fukai K, Yokosuka O, Imazeki F, Tada M, Mikata R, Miyazaki M, Ochiai T, Saisho H. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma. Liver Int. 2005;25:1209-1216. [PMID: 16343074 DOI: 10.1111/j.1478-3231.2005.01162.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
278 Hesson LB, Krex D, Latif F. Epigenetic markers in human gliomas: prospects for therapeutic intervention. Expert Rev Neurother 2008;8:1475-96. [PMID: 18928342 DOI: 10.1586/14737175.8.10.1475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
279 Brown CA, Bogers J, Sahebali S, Depuydt CE, De Prins F, Malinowski DP. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. J Oncol 2012;2012:289315. [PMID: 22481919 DOI: 10.1155/2012/289315] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
280 Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res. 2000;462:31-47. [PMID: 10648922 DOI: 10.1016/s1383-5742(99)00091-5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
281 Mayr B, Wilhelm B, Reifinger M, Brem G. Absence of p21 WAF1 and p27 kip1 gene mutations in various feline tumours. Vet Res Commun 2000;24:115-24. [PMID: 10720097 DOI: 10.1023/a:1006412623142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
282 Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, Storz M, Seifert B, Marino S, Schraml P. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007;121:1764-1770. [PMID: 17597110 DOI: 10.1002/ijc.22891] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
283 Mohiuddin M, Kasahara K. Cisplatin Activates the Growth Inhibitory Signaling Pathways by Enhancing the Production of Reactive Oxygen Species in Non-small Cell Lung Cancer Carrying an EGFR Exon 19 Deletion. Cancer Genomics Proteomics 2021;18:471-86. [PMID: 33994369 DOI: 10.21873/cgp.20273] [Reference Citation Analysis]
284 Onishi T, Hruska K. Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology 1997;138:1995-2004. [PMID: 9112398 DOI: 10.1210/endo.138.5.5146] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 1.7] [Reference Citation Analysis]
285 Dong Y, Walsh MD, Mcguckin MA, Gabrielli BB, Cummings MC, Wright RG, Hurst T, Khoo SK, Parsons PG. Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis. Int J Cancer 1997;74:57-63. [DOI: 10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f] [Cited by in Crossref: 54] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
286 Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch. 1996;429:13-19. [PMID: 8865848 DOI: 10.1007/BF00196815] [Cited by in Crossref: 38] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
287 Sherburn TE, Gale JM, Ley RD. Cloning and Characterization of the CDKN2A and p19ARF Genes from Monodelphis domestica. DNA and Cell Biology 1998;17:975-81. [DOI: 10.1089/dna.1998.17.975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
288 Lee CCR, Fukushima S. Review article Alterations in cyclin D1, p53, and the cell cycle related elements. Urologic Oncology: Seminars and Original Investigations 1998;4:58-72. [DOI: 10.1016/s1078-1439(98)00033-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
289 Herzog CR, You M. Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene. Mammalian Genome 1997;8:65-6. [DOI: 10.1007/s003359900352] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
290 Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene 2003;22:4444-8. [PMID: 12853981 DOI: 10.1038/sj.onc.1206564] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
291 Quesnel B, Preudhomme C, Fenaux P. p16 ink4a Gene and Hematological Malignancies. Leukemia & Lymphoma 2009;22:11-24. [DOI: 10.3109/10428199609051724] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
292 E Hermosilla V, Salgado G, Riffo E, Escobar D, Hepp MI, Farkas C, Galindo M, Morín V, García-Robles MA, Castro AF, Pincheira R. SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes. Mol Oncol 2018;12:1026-46. [PMID: 29689621 DOI: 10.1002/1878-0261.12308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
293 Kato JY, Matsuoka M, Polyak K, Massagué J, Sherr CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell. 1994;79:487-496. [PMID: 7954814 DOI: 10.1016/0092-8674(94)90257-7] [Cited by in Crossref: 511] [Cited by in F6Publishing: 521] [Article Influence: 18.3] [Reference Citation Analysis]
294 Fujita M, Enomoto T, Haba T, Nakashima R, Sasaki M, Yoshino K, Wada H, Buzard GS, Matsuzaki N, Wakasa K, Murata Y. Alteration of p16 and p15 genes in common epithelial ovarian tumors. Int J Cancer 1997;74:148-55. [PMID: 9133447 DOI: 10.1002/(sici)1097-0215(19970422)74:2<148::aid-ijc2>3.0.co;2-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
295 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(15): 1909-1912 [DOI: 10.11569/wcjd.v13.i15.1909] [Reference Citation Analysis]
296 Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756. [PMID: 8152487 DOI: 10.1038/368753a0] [Cited by in Crossref: 1110] [Cited by in F6Publishing: 1055] [Article Influence: 39.6] [Reference Citation Analysis]
297 Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 1996;93:13742-7. [PMID: 8943005 DOI: 10.1073/pnas.93.24.13742] [Cited by in Crossref: 626] [Cited by in F6Publishing: 584] [Article Influence: 25.0] [Reference Citation Analysis]
298 Danthinne X, Aoki K, Kurachi AL, Nabel GJ, Nabel EG. Combination Gene Delivery of the Cell Cycle Inhibitor p27 with Thymidine Kinase Enhances Prodrug Cytotoxicity. J Virol 1998;72:9201-7. [DOI: 10.1128/jvi.72.11.9201-9207.1998] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Mishra A, Pandey A, Nong X. Head and Neck Squamous Cell Cancer: Biology (II) and Translational Methods. Indian J Otolaryngol Head Neck Surg 2007;59:245-51. [PMID: 23120443 DOI: 10.1007/s12070-007-0071-9] [Reference Citation Analysis]
300 Gao X, Honn KV. Chapter 5 Molecular biology of prostate cancer. The Oncobiology of the Prostate. Elsevier; 1999. pp. 85-122. [DOI: 10.1016/s1569-254x(99)80006-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
301 Ou L, Ferreira AM, Otieno S, Xiao L, Bashford D, Kriwacki RW. Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein. J Biol Chem 2011;286:30142-51. [PMID: 21715330 DOI: 10.1074/jbc.M111.244095] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
302 Schuyer M, van Staveren IL, Klijn JG, vd Burg ME, Stoter G, Henzen-Logmans SC, Foekens JA, Berns EM. Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours. Br J Cancer 1996;74:1069-73. [PMID: 8855976 DOI: 10.1038/bjc.1996.491] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
303 Gotoh A, Kao C, Ko S, Hamada K, Liu T, Chung LWK. Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers: . The Journal of Urology. [DOI: 10.1097/00005392-199708000-00106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
304 King KL, Cidlowski JA. Cell cycle and apoptosis: Common pathways to life and death. J Cell Biochem 1995;58:175-80. [DOI: 10.1002/jcb.240580206] [Cited by in Crossref: 253] [Cited by in F6Publishing: 249] [Article Influence: 9.4] [Reference Citation Analysis]
305 Wang E, Liu D. Characterization of senescence- and apoptosis-dependent forms of terminin as derived from a precursor found in replicating and nonreplicating cells. J Cell Biochem 1996;60:107-20. [DOI: 10.1002/(sici)1097-4644(19960101)60:1<107::aid-jcb13>3.0.co;2-m] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
306 Low KG, Dorner LF, Fernando DB, Grossman J, Jeang KT, Comb MJ. Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J Virol 1997;71:1956-62. [PMID: 9032327 DOI: 10.1128/JVI.71.3.1956-1962.1997] [Cited by in Crossref: 106] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
307 Kannengiesser C, Brookes S, del Arroyo AG, Pham D, Bombled J, Barrois M, Mauffret O, Avril MF, Chompret A, Lenoir GM, Sarasin A, Peters G, Bressac-de Paillerets B; French Hereditary Melanoma Study Group. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. Hum Mutat 2009;30:564-74. [PMID: 19260062 DOI: 10.1002/humu.20845] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
308 Krtolica K, Krajnovic M, Usaj-Knezevic S, Babic D, Jovanovic D, Dimitrijevic B. Comethylation of p16 and MGMT genes in colorectal carcinoma: Correlation with clinicopathological features and prognostic value. World J Gastroenterol 2007; 13(8): 1187-1194 [PMID: 17451198 DOI: 10.3748/wjg.v13.i8.1187] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
309 Herrera RE. The Growth-Inhibitory Effects of TGFβ. In: Macieira-coelho A, editor. Inhibitors of Cell Growth. Berlin: Springer Berlin Heidelberg; 1998. pp. 11-24. [DOI: 10.1007/978-3-642-72149-6_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
310 Parry D, Mahony D, Wills K, Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999;19:1775-83. [PMID: 10022865 DOI: 10.1128/MCB.19.3.1775] [Cited by in Crossref: 118] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
311 Wu CM, Huang TH, Xie QD, Wu DS, Xu XH. Expression properties of recombinant pEgr-P16 plasmid in esophageal squamous cell carcinoma induced by ionizing irradiation. World J Gastroenterol 2003; 9(12): 2650-2653 [PMID: 14669305 DOI: 10.3748/wjg.v9.i12.2650] [Reference Citation Analysis]
312 He G, Siddik ZH, Huang Z, Wang R, Koomen J, Kobayashi R, Khokhar AR, Kuang J. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 2005;24:2929-43. [PMID: 15735718 DOI: 10.1038/sj.onc.1208474] [Cited by in Crossref: 159] [Cited by in F6Publishing: 154] [Article Influence: 9.4] [Reference Citation Analysis]
313 Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS, Brielmeier M, Ellwart J, Kohlhuber F, Bornkamm GW. Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int J Cancer. 2000;87:787-793. [PMID: 10956386 DOI: 10.1002/1097-0215(20000915)87:6%3C787::AID-IJC4%3E3.0.CO;2-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Packenham JP, Taylor JA, Anna CH, White CM, Devereux TR. Homozygous deletions but no sequence mutations in coding regions ofp15 orp16 in human primary bladder tumors. Mol Carcinog 1995;14:147-51. [DOI: 10.1002/mc.2940140303] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.7] [Reference Citation Analysis]
315 Machiavelli G, Cotignola J, Danilowicz K, Carbonara C, Paes de Lima A, Basso A, Bruno OD, Szijan I. Expression of p16(INK4A) gene in human pituitary tumours. Pituitary 2008;11:71-5. [PMID: 18058237 DOI: 10.1007/s11102-007-0077-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
316 Bird R. The Cyclin/Cyclin-Dependent Kinase (cdk) Complex. Nuclear Structure and Gene Expression. Elsevier; 1997. pp. 145-74. [DOI: 10.1016/b978-012100160-5/50006-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
317 Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995;269:1281-4. [PMID: 7652577 DOI: 10.1126/science.7652577] [Cited by in Crossref: 769] [Cited by in F6Publishing: 655] [Article Influence: 28.5] [Reference Citation Analysis]
318 Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000;26:29-52. [PMID: 10660490 DOI: 10.1053/ctrv.1999.0144] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 2.5] [Reference Citation Analysis]
319 Zhou JX, Niehans GA, Shar A, Rubins JB, Frizelle SP, Kratzke RA. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer. Lung Cancer. 2001;32:27-38. [PMID: 11282426 DOI: 10.1016/S0169-5002(00)00210-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
320 Zhang H, Chen ZH, Savarese TM. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines. Cancer Genet Cytogenet 1996;86:22-8. [PMID: 8616780 DOI: 10.1016/0165-4608(95)00157-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
321 Wei M, Wang Z, Yao H, Yang Z, Zhang Q, Liu B, Yu Y, Su L, Zhu Z, Gu Q. P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells. BMC Cancer 2011;11:109. [PMID: 21439087 DOI: 10.1186/1471-2407-11-109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
322 Giroux MA, Audrezet MP, Metges JP, Lozac'h P, Volant A, Nousbaum JB, Labat JP, Gouérou H, Ferec C, Robaszkiewicz M. Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol. 2002;14:15-18. [PMID: 11782570 DOI: 10.1097/00042737-200201000-00004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
323 Petropoulou C, Chondrogianni N, Simões D, Agiostratidou G, Drosopoulos N, Kotsota V, Gonos ES. Aging and Longevity: A Paradigm of Complementation between Homeostatic Mechanisms and Genetic Control? Annals of the New York Academy of Sciences 2000;908:133-42. [DOI: 10.1111/j.1749-6632.2000.tb06642.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
324 Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity. Journal of Biological Chemistry 2005;280:5812-9. [DOI: 10.1074/jbc.m411429200] [Cited by in Crossref: 111] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
325 Warbrick E, Glover D. A Drosophila gene encoding a DEAD box RNA helicase can suppress loss of wee1/mik1 function in Schizosaccharomyces pombe. Molec Gen Genet 1994;245:654-7. [DOI: 10.1007/bf00282229] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
326 Tatsuno I, Hirai A, Saito Y. Cell-anchorage, cell cytoskeleton, and Rho-GTPase family in regulation of cell cycle progression. In: Meijer L, Jézéquel A, Ducommun B, editors. Progress in Cell Cycle Research. Boston: Springer US; 2000. pp. 19-25. [DOI: 10.1007/978-1-4615-4253-7_2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
327 Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke–related cholangiocarcinoma. Human Pathology 2009;40:817-26. [DOI: 10.1016/j.humpath.2008.11.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
328 Eissa S, Ali-Labib R, Khalifa A. Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC). Clin Chim Acta. 2000;300:159-169. [PMID: 10958872 DOI: 10.1016/s0009-8981(00)00317-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
329 Yamada H, Ochi K, Nakada S, Takahara S, Nemoto T, Sekikawa T, Horiguchi-yamada J. Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells. Mol Cell Biochem 1995;152:149-58. [DOI: 10.1007/bf01076077] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
330 Koscielny S, Dahse R, Ernst G, von Eggeling F. The prognostic relevance of p16 inactivation in head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2007;69:30-36. [PMID: 17085950 DOI: 10.1159/000096714] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
331 Yokota T, Matsuzaki Y, Sakai T. Trichostatin A activates p18INK4c gene: differential activation and cooperation with p19INK4d gene. FEBS Lett 2004;574:171-5. [PMID: 15358560 DOI: 10.1016/j.febslet.2004.08.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
332 Piccinin S, Doglioni C, Maestro R, Vukosavijevic T, Gasparotto D, D'orazi C, Boiocchi M. p16/CDKN2 andCDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer 1997;74:26-30. [DOI: 10.1002/(sici)1097-0215(19970220)74:1<26::aid-ijc5>3.0.co;2-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
333 Machen S, Prayson RA. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: A study of 48 cases. Human Pathology 1998;29:1511-6. [DOI: 10.1016/s0046-8177(98)90023-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
334 Fernández PL, Jares P, Rey MJ, Campo E, Cardesa A. Cell cycle regulators and their abnormalities in breast cancer. Mol Pathol. 1998;51:305-309. [PMID: 10193510 DOI: 10.1136/mp.51.6.305] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
335 Attri J, Srinivasan R, Majumdar S, Radotra BD, Wig J. Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma. BMC Gastroenterol. 2005;5:22. [PMID: 15985168 DOI: 10.1186/1471-230x-5-22] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
336 Bury M, Le Calvé B, Ferbeyre G, Blank V, Lessard F. New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy. Trends Cell Biol 2021;31:331-44. [PMID: 33676803 DOI: 10.1016/j.tcb.2021.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
337 Goldstein AM, Tucker MA. Genetic Epidemiology of Familial Melanoma. Dermatologic Clinics 1995;13:605-12. [DOI: 10.1016/s0733-8635(18)30066-4] [Cited by in Crossref: 53] [Article Influence: 2.0] [Reference Citation Analysis]
338 Braun P. Interactome mapping for analysis of complex phenotypes: insights from benchmarking binary interaction assays. Proteomics 2012;12:1499-518. [PMID: 22589225 DOI: 10.1002/pmic.201100598] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
339 Ghiorzo P, Mantelli M, Gargiulo S, Gramigni C, Pastorino L, Banelli B, Villaggio B, Coccia MC, Sementa AR, Garrè C, Bianchi-Scarrà G. Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression. Hum Pathol 2004;35:1029-37. [PMID: 15297971 DOI: 10.1016/j.humpath.2004.02.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
340 Inohara S, Kitagawa K, Kitano Y. TARGET OF SKIN TUMORIGENESIS: CYCLIN D1-CDK4. Int J Dermatol 1996;35:609-13. [DOI: 10.1111/j.1365-4362.1996.tb03681.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
341 Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14-32. [PMID: 18096889 DOI: 10.1177/154405910808700104] [Cited by in Crossref: 259] [Cited by in F6Publishing: 236] [Article Influence: 18.5] [Reference Citation Analysis]
342 Indovina P, Marcelli E, Casini N, Rizzo V, Giordano A. Emerging roles of RB family: new defense mechanisms against tumor progression. J Cell Physiol 2013;228:525-35. [PMID: 22886479 DOI: 10.1002/jcp.24170] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
343 Jennings GS, Strauss M. Immortalization of Hepatocytes through Targeted Deregulation of the Cell Cycle. In: Al-rubeai M, editor. Cell Engineering. Dordrecht: Springer Netherlands; 1999. pp. 255-87. [DOI: 10.1007/978-0-585-37971-5_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
344 Santillan AA, Cherpelis BS, Glass LF, Sondak VK. Management of familial melanoma and nonmelanoma skin cancer syndromes. Surg Oncol Clin N Am 2009;18:73-98, viii. [PMID: 19056043 DOI: 10.1016/j.soc.2008.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
345 Ito Y, Kobayashi T, Takeda T, Komoike Y, Wakasugi E, Tamaki Y, Umeshita K, Monden T, Monden M. Immunohistochemical study of cell cycle modulators in G1-S transition in clinical breast cancer tissue. Breast Cancer 1996;3:93-104. [DOI: 10.1007/bf02966969] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
346 Nakashima R, Fujita M, Enomoto T, Haba T, Yoshino K, Wada H, Kurachi H, Sasaki M, Wakasa K, Inoue M, Buzard G, Murata Y. Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 1999;80:458-67. [PMID: 10408854 DOI: 10.1038/sj.bjc.6690379] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 2.7] [Reference Citation Analysis]
347 Korgun ET, Unek G, Herrera E, Jones CJ, Wadsack C, Kipmen-korgun D, Desoye G. Mapping of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta. Histochem Cell Biol 2011;136:267-78. [DOI: 10.1007/s00418-011-0841-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
348 Cha S, Jang KL. Hepatitis B virus X protein stimulates cell growth by downregulating p16 levels via PA28γ-mediated proteasomal degradation. J Gen Virol 2020;101:963-71. [PMID: 32568029 DOI: 10.1099/jgv.0.001461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Kurita S, Ohkoshi S, Yano M, Yamazaki K, Suzuki K, Aoki YH, Matsuda Y, Wakai T, Shirai Y, Ichida T, Aoyagi Y. Progression of hypermethylation of the p16(INK4A) gene from normal liver to nontumorous liver and hepatocellular carcinoma: an evaluation using quantitative PCR analysis. Dig Dis Sci 2009;54:80-8. [PMID: 19016326 DOI: 10.1007/s10620-008-0611-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
350 Zhang S, Ramsay ES, Mock BA. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc Natl Acad Sci U S A 1998;95:2429-34. [PMID: 9482902 DOI: 10.1073/pnas.95.5.2429] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 4.3] [Reference Citation Analysis]
351 Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A 1996;93:7905-10. [PMID: 8755575 DOI: 10.1073/pnas.93.15.7905] [Cited by in Crossref: 180] [Cited by in F6Publishing: 159] [Article Influence: 6.9] [Reference Citation Analysis]
352 Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene. 2003;22:9007-9021. [PMID: 14663479 DOI: 10.1038/sj.onc.1207261] [Cited by in Crossref: 333] [Cited by in F6Publishing: 308] [Article Influence: 18.5] [Reference Citation Analysis]
353 Williams SG, Stein JP. Molecular pathways in bladder cancer. Urol Res 2004;32:373-85. [DOI: 10.1007/s00240-003-0345-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
354 Wang R. Tumor Antigens Discovery: Perspectives for Cancer Therapy. Mol Med 1997;3:716-31. [DOI: 10.1007/bf03401710] [Cited by in Crossref: 13] [Article Influence: 0.5] [Reference Citation Analysis]
355 Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, Schorderet D, Bosman FT, Chaubert P. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001;81:217-29. [PMID: 11232644 DOI: 10.1038/labinvest.3780230] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 5.4] [Reference Citation Analysis]
356 Laco J, Slaninka I, Jirásek M, Celakovský P, Vosmiková H, Ryska A. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. Pathol Res Pract 2008;204:545-52. [PMID: 18440161 DOI: 10.1016/j.prp.2008.03.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
357 Bae HJ, Kang SK, Kwon WS, Jeong I, Park S, Kim TS, Kim KH, Kim H, Jeong HC, Chung HC, Rha SY. p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer. Biochem Pharmacol 2021;183:114320. [PMID: 33161023 DOI: 10.1016/j.bcp.2020.114320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
358 Song W, Liu Y, Liu Y, Zhang C, Yuan B, Zhang L, Sun S. Increased p16 DNA methylation in mouse thymic lymphoma induced by irradiation. PLoS One 2014;9:e93850. [PMID: 24747802 DOI: 10.1371/journal.pone.0093850] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
359 Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, Kohno Y, Ito K, Fujibayashi S, Neo M, Nakayama T, Nakamura T, Toguchida J. Expression of the p16INK4A Gene Is Associated Closely with Senescence of Human Mesenchymal Stem Cells and Is Potentially Silenced by DNA Methylation During In Vitro Expansion. STEM CELLS 2007;25:2371-82. [DOI: 10.1634/stemcells.2007-0225] [Cited by in Crossref: 161] [Cited by in F6Publishing: 150] [Article Influence: 12.4] [Reference Citation Analysis]
360 Santos M, Landolfi S, Olivella A, Lloveras B, Klaustermeier J, Suárez H, Alòs L, Puig-Tintoré LM, Campo E, Ordi J. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006;30:1347-56. [PMID: 17063073 DOI: 10.1097/01.pas.0000213251.82940.bf] [Cited by in Crossref: 116] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
361 Allegra E, Caltabiano R, Amorosi A, Vasquez E, Garozzo A, Puzzo L. Expression of BMI1 and p16 in laryngeal squamous cell carcinoma. Head Neck 2013;35:847-51. [PMID: 22730165 DOI: 10.1002/hed.23042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
362 Kawabe S, Roth JA, Wilson DR, Meyn RE. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner. Oncogene 2000;19:5359-66. [PMID: 11103937 DOI: 10.1038/sj.onc.1203935] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
363 Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A. Retinoblastoma-Related Protein pRb2/p130 and Suppression of Tumor Growth In Vivo. JNCI: Journal of the National Cancer Institute 1998;90:1451-60. [DOI: 10.1093/jnci/90.19.1451] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.5] [Reference Citation Analysis]
364 Hall IJ, Gioeli D, Weissman BE, Tlsty TD. Identification of additional complementation groups that regulate genomic instability. Genes Chromosom Cancer 1997;20:103-12. [DOI: 10.1002/(sici)1098-2264(199710)20:2<103::aid-gcc1>3.0.co;2-7] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
365 Said TK, Medina D. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Mol Carcinog 1998;22:128-43. [DOI: 10.1002/(sici)1098-2744(199806)22:2<128::aid-mc8>3.0.co;2-i] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
366 Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res 2009;88:300-6. [PMID: 19407148 DOI: 10.1177/0022034509333371] [Cited by in Crossref: 103] [Cited by in F6Publishing: 80] [Article Influence: 7.9] [Reference Citation Analysis]
367 Ramakrishnan S, Partricia S, Mathan G. Overview of high-risk HPV's 16 and 18 infected cervical cancer: Pathogenesis to prevention. Biomedicine & Pharmacotherapy 2015;70:103-10. [DOI: 10.1016/j.biopha.2014.12.041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
368 Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol. 1999;287:821-828. [PMID: 10222191 DOI: 10.1006/jmbi.1999.2640] [Cited by in Crossref: 459] [Cited by in F6Publishing: 443] [Article Influence: 20.0] [Reference Citation Analysis]
369 Uchida T, Kinoshita T, Nagai H, Nakahara Y, Saito H, Hotta T, Murate T. Hypermethylation of the p15INK4B Gene in Myelodysplastic Syndromes. Blood 1997;90:1403-9. [DOI: 10.1182/blood.v90.4.1403] [Cited by in Crossref: 200] [Article Influence: 8.0] [Reference Citation Analysis]
370 Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal: . Current Opinion in Oncology 2000;12:240-5. [DOI: 10.1097/00001622-200005000-00009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
371 Chao HH, Buchmann AM, DeCaprio JA. Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation. Mol Cell Biol 2000;20:7624-33. [PMID: 11003658 DOI: 10.1128/MCB.20.20.7624-7633.2000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
372 Akhlaghipour I, Bina AR, Abbaszadegan MR, Moghbeli M. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview. Genes Environ 2021;43:14. [PMID: 33883026 DOI: 10.1186/s41021-021-00187-1] [Reference Citation Analysis]
373 Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T. Inactivation of the p14ARF, p15INK4B and p16INK4A genes is a frequent event in human oral squamous cell carcinomas. Oral Oncology 2001;37:498-504. [DOI: 10.1016/s1368-8375(00)00142-1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
374 Tsui LV, Camrud A, Mondesire J, Carlson P, Zayek N, Camrud L, Donahue B, Bauer S, Lin A, Frey D, Rivkin M, Subramanian A, Falotico R, Gyuris J, Schwartz R, Mcarthur JG. p27-p16 Fusion Gene Inhibits Angioplasty-Induced Neointimal Hyperplasia and Coronary Artery Occlusion. Circulation Research 2001;89:323-8. [DOI: 10.1161/hh1601.094482] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
375 Anzola M, Cuevas N, López-Martínez M, Saiz A, Burgos JJ, Martínez de Pancorboa M. P14ARF gene alterations in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2004;16:19-26. [PMID: 15095848 DOI: 10.1097/00042737-200401000-00004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
376 Fung C, Pupo GM, Scolyer RA, Kefford RF, Rizos H. p16 INK4a deficiency promotes DNA hyper-replication and genetic instability in melanocytes. Pigment Cell Melanoma Res 2013;26:236-46. [DOI: 10.1111/pcmr.12062] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
377 Tominaga K. The emerging role of senescent cells in tissue homeostasis and pathophysiology. Pathobiol Aging Age Relat Dis 2015;5:27743. [PMID: 25994420 DOI: 10.3402/pba.v5.27743] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
378 Serrano M, Gómez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science. 1995;267:249-252. [PMID: 7809631 DOI: 10.1126/science.7809631] [Cited by in Crossref: 266] [Cited by in F6Publishing: 260] [Article Influence: 9.9] [Reference Citation Analysis]
379 Giordano G, Azzoni C, D'Adda T, Rocco A, Gnetti L, Froio E, Merisio C, Melpignano M. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms. Pathol Res Pract 2008;204:163-74. [PMID: 18180113 DOI: 10.1016/j.prp.2007.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
380 Franco J, Witkiewicz AK, Knudsen ES. CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer. Oncotarget 2014;5:6512-25. [PMID: 25156567 DOI: 10.18632/oncotarget.2270] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 17.9] [Reference Citation Analysis]
381 Jagasia AA, Block JA, Diaz MO, Nobori T, Gitelis S, Inerot SE, Iyer AP. Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma. Cancer Letters 1996;105:77-90. [DOI: 10.1016/0304-3835(96)04273-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
382 Namazie A, Alavi S, Aghamohammadi N, Aghamohammadi M, Calcaterra TC, Wang MB, Srivatsan ES. Fluorescence in situ hybridization for detecting TP16MTS1/CDK41 gene deletions in squamous cell carcinoma of the head and neck. Cancer Genetics and Cytogenetics 2003;141:49-55. [DOI: 10.1016/s0165-4608(02)00658-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
383 Agarwal P, Deinnocentes P, Bird RC. Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation. In Vitro Cell Dev Biol -Animal 2018;54:658-65. [DOI: 10.1007/s11626-018-0291-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
384 Soufir N, Bressac-de Paillerets B, Desjardins L, Lévy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Br J Cancer 2000;82:818-22. [PMID: 10732752 DOI: 10.1054/bjoc.1999.1005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
385 Pedroza-Saavedra A, Lam EW, Esquivel-Guadarrama F, Gutierrez-Xicotencatl L. The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1). Virology 2010;400:44-52. [PMID: 20144468 DOI: 10.1016/j.virol.2010.01.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
386 Wangari-Talbot J, Chen S. Genetics of melanoma. Front Genet 2012;3:330. [PMID: 23372575 DOI: 10.3389/fgene.2012.00330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
387 Kalatskaya I. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma. Ann N Y Acad Sci 2016;1381:74-91. [PMID: 27415609 DOI: 10.1111/nyas.13134] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
388 Flick JS, Thorner J. An Essential Function of a Phosphoinositide-Specific Phospholipase C Is Relieved by Inhibition of a Cyclin-Dependent Protein Kinase in the Yeast Saccharomyces cerevisiae. Genetics 1998;148:33-47. [DOI: 10.1093/genetics/148.1.33] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
389 Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol 1999;155:1879-84. [PMID: 10595918 DOI: 10.1016/S0002-9440(10)65507-1] [Cited by in Crossref: 170] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
390 Sung YH, Park J, Choi B, Kim J, Cheong C, Choi YS, Yang EY, Lee M, Han JS, Park SC, Han T, Kim TJ, Song J, Rhee K, Lee H. Hematopoietic malignancies associated with increased Stat5 and Bcl-xL expressions in Ink4a/Arf-deficient mice. Mechanisms of Ageing and Development 2005;126:732-9. [DOI: 10.1016/j.mad.2005.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
391 Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov 2015;14:130-46. [PMID: 25633797 DOI: 10.1038/nrd4504] [Cited by in Crossref: 805] [Cited by in F6Publishing: 749] [Article Influence: 115.0] [Reference Citation Analysis]
392 Tago K, Chiocca S, Sherr CJ. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci U S A 2005;102:7689-94. [PMID: 15897463 DOI: 10.1073/pnas.0502978102] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 4.3] [Reference Citation Analysis]
393 Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, Viskochil DH. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol 2003;27:1337-45. [PMID: 14508395 DOI: 10.1097/00000478-200310000-00006] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
394 Queiroz C, Silva TC, Alves VA, Villa LL, Costa MC, Travassos AG, Filho JB, Studart E, Cheto T, de Freitas LA. Comparative study of the expression of cellular cycle proteins in cervical intraepithelial lesions. Pathol Res Pract 2006;202:731-7. [PMID: 16979303 DOI: 10.1016/j.prp.2006.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
395 Shirin H, Hibshoosh H, Kawabata Y, Weinstein IB, Moss SF. p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis. Helicobacter. 2003;8:66-71. [PMID: 12603618 DOI: 10.1046/j.1523-5378.2003.00125.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
396 Wang X, Pan L, Feng Y, Wang Y, Han Q, Han L, Han S, Guo J, Huang B, Lu J. P300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene 2008;27:1894-904. [PMID: 17906698 DOI: 10.1038/sj.onc.1210821] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
397 Gotoh A, Kao C, Ko S, Hamada K, Liu T, Chung LW. Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers. Journal of Urology 1997;158:636-41. [DOI: 10.1016/s0022-5347(01)64574-9] [Cited by in Crossref: 44] [Article Influence: 1.8] [Reference Citation Analysis]
398 Siebert R, Willers CP, Opalka B. Role of the Cyclin-Dependent Kinase 4 and 6 Inhibitor Gene Family p15, p16, p18 and p19 in Leukemia and Lymphoma. Leukemia & Lymphoma 2009;23:505-20. [DOI: 10.3109/10428199609054859] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
399 Tran T, Ross JS, Carlson JA, Mihm MC. Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions. Human Pathology 1998;29:1085-90. [DOI: 10.1016/s0046-8177(98)90418-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
400 Wang Y, Zhang Z, Lubet R, You M. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf. Oncogene 2005;24:3042-9. [PMID: 15846305 DOI: 10.1038/sj.onc.1208390] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
401 Silva JM, Dominguez G, Villanueva MJ, Gonzalez R, Garcia JM, Corbacho C, Provencio M, España P, Bonilla F. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer 1999;80:1262-4. [PMID: 10376981 DOI: 10.1038/sj.bjc.6690495] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 3.4] [Reference Citation Analysis]
402 Fu Z, Ma Z, Wang Q, Lei D, Wang R, Liu C, Pan X. Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients. Clin Exp Metastasis 2008;25:887-92. [DOI: 10.1007/s10585-008-9207-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
403 Ivanchuk SM, Mondal S, Dirks PB, Rutka JT. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth. J Neurooncol 2001;51:219-29. [PMID: 11407594 DOI: 10.1023/a:1010632309113] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
404 Shimizu T, Awai N, Takeda K. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells. Oncogene 2000;19:4640-6. [DOI: 10.1038/sj.onc.1203821] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
405 Ruas M, Gregory F, Jones R, Poolman R, Starborg M, Rowe J, Brookes S, Peters G. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol 2007;27:4273-82. [PMID: 17420273 DOI: 10.1128/MCB.02286-06] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
406 Meijer L. Chemical inhibitors of cyclin-dependent kinases. In: Meijer L, Guidet S, Tung HYL, editors. Progress in Cell Cycle Research. Boston: Springer US; 1995. pp. 351-63. [DOI: 10.1007/978-1-4615-1809-9_29] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 1.4] [Reference Citation Analysis]
407 Hashi A, Xu J, Kondo T, Hashi K, Yuminamochi T, Nara M, Murata S, Katoh R, Hoshi K. p16INK4a Overexpression Independent of Human Papillomavirus Infection in Lobular Endocervical Glandular Hyperplasia: . International Journal of Gynecological Pathology 2006;25:187-94. [DOI: 10.1097/01.pgp.0000179612.63085.70] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
408 Tse JY, Ng H, Lo K, Chong EY, Lam PY, Ng EK, Poon W, Huang DP. Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas. Human Pathology 1998;29:1200-7. [DOI: 10.1016/s0046-8177(98)90246-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
409 Møller M, Kania P, Ino Y, Gerdes A, Nielsen O, Louis D, Skjødt K, Pedersen N. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. Leukemia 2000;14:898-904. [DOI: 10.1038/sj.leu.2401761] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
410 Zhou J, Cao J, Lu Z, Liu H, Deng D. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues. BMC Med Genet 2011;12:67. [PMID: 21569495 DOI: 10.1186/1471-2350-12-67] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
411 Castellano M, Gabrielli BG, Hussussian CJ, Dracopoli NC, Hayward NK. Restoration of CDKN2A into Melanoma Cells Induces Morphologic Changes and Reduction in Growth Rate but Not Anchorage-Independent Growth Reversal. Journal of Investigative Dermatology 1997;109:61-8. [DOI: 10.1111/1523-1747.ep12276538] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
412 Tanaka H, Fujii Y, Hirabayashi H, Miyoshi S, Sakaguchi M, Yoon HE, Matsuda H. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers. Int J Cancer 1998;79:111-5. [PMID: 9583722 DOI: 10.1002/(sici)1097-0215(19980417)79:2<111::aid-ijc2>3.0.co;2-w] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
413 Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994;79:573-582. [PMID: 7954824 DOI: 10.1016/0092-8674(94)90543-6] [Cited by in Crossref: 1436] [Cited by in F6Publishing: 1435] [Article Influence: 51.3] [Reference Citation Analysis]
414 Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38. [PMID: 21489289 DOI: 10.1186/1476-4598-10-38] [Cited by in Crossref: 1002] [Cited by in F6Publishing: 1045] [Article Influence: 91.1] [Reference Citation Analysis]
415 Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 2001;15:1370-80. [PMID: 11463860 DOI: 10.1210/mend.15.8.0673] [Cited by in Crossref: 12] [Cited by in F6Publishing: 71] [Article Influence: 0.6] [Reference Citation Analysis]
416 Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M, Bartek J. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J Cancer. 1995;61:115-120. [PMID: 7705923 DOI: 10.1002/ijc.2910610120] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 3.0] [Reference Citation Analysis]
417 Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan RC, Le QT. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol 2014;32:3930-8. [PMID: 25267748 DOI: 10.1200/JCO.2013.54.5228] [Cited by in Crossref: 230] [Cited by in F6Publishing: 130] [Article Influence: 28.8] [Reference Citation Analysis]
418 Tonini T, Hillson C, Claudio PP. Interview with the retinoblastoma family members: Do they help each other? J Cell Physiol 2002;192:138-50. [DOI: 10.1002/jcp.10117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
419 Nikitin AG, Potapov VA, Brovkin AN, Lavrikova EY, Khodyrev DS, Shamhalova MS, Smetanina SA, Suplotova LN, Shestakova MV, Nosikov VV, Averyanov AV. Association of FTO, KCNJ11, SLC30A8, and CDKN2B polymorphisms with type 2 diabetes mellitus. Mol Biol 2015;49:103-11. [DOI: 10.1134/s0026893315010112] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
420 Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Cancer Radiother. 2001;5:109-129. [PMID: 11355576 DOI: 10.1016/s1278-3218(01)00087-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
421 Naderi S, Wang JY, Chen TT, Gutzkow KB, Blomhoff HK. cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA. Mol Biol Cell 2005;16:1527-42. [PMID: 15647383 DOI: 10.1091/mbc.e04-06-0501] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
422 Arya AK, Bhadada SK, Singh P, Sachdeva N, Saikia UN, Dahiya D, Behera A, Bhansali A, Rao SD. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas. Sci Rep 2017;7:3123. [PMID: 28600574 DOI: 10.1038/s41598-017-03143-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
423 Harbour J. Tumor Suppressor Genes in Ophthalmology. Survey of Ophthalmology 1999;44:235-46. [DOI: 10.1016/s0039-6257(99)00102-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
424 Driscoll B, Wu L, Buckley S, Hall FL, Anderson KD, Warburton D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am J Physiol 1997;273:L941-9. [PMID: 9374720 DOI: 10.1152/ajplung.1997.273.5.L941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
425 Fujita K. p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions. Int J Mol Sci 2019;20:E6023. [PMID: 31795382 DOI: 10.3390/ijms20236023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
426 Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res. 2000;24:39-46. [PMID: 10634644 DOI: 10.1016/s0145-2126(99)00158-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
427 Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220-228. [PMID: 20177397 DOI: 10.1038/nrm2858] [Cited by in Crossref: 1203] [Cited by in F6Publishing: 1111] [Article Influence: 100.3] [Reference Citation Analysis]
428 Mora J, Alaminos M, de Torres C, Illei P, Qin J, Cheung NK, Gerald WL. Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours. Br J Cancer 2004;91:1112-8. [PMID: 15305192 DOI: 10.1038/sj.bjc.6602094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
429 Inoue K, Roussel MF, Sherr CJ. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc Natl Acad Sci U S A 1999;96:3993-8. [PMID: 10097151 DOI: 10.1073/pnas.96.7.3993] [Cited by in Crossref: 103] [Cited by in F6Publishing: 110] [Article Influence: 4.5] [Reference Citation Analysis]
430 Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bueno-de-Mesquita HB, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks R, Vashist Y, Gioffreda D, Strobel O, Shimizu Y, Dijk F, Andriulli A, Ivanauskas A, Bugert P, Tavano F, Vodickova L, Zambon CF, Lovecek M, Landi S, Key TJ, Boggi U, Pezzilli R, Jamroziak K, Mohelnikova-Duchonova B, Mambrini A, Bambi F, Busch O, Pazienza V, Valente R, Theodoropoulos GE, Hackert T, Capurso G, Cavestro GM, Pasquali C, Basso D, Sperti C, Matsuo K, Büchler M, Khaw KT, Izbicki J, Costello E, Katzke V, Michalski C, Stepien A, Rizzato C, Canzian F. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget 2016;7:57011-20. [PMID: 27486979 DOI: 10.18632/oncotarget.10935] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
431 Malumbres M, Pérez De Castro I, Hernández MI, Jiménez M, Corral T, Pellicer A. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol Cell Biol 2000;20:2915-25. [PMID: 10733595 DOI: 10.1128/MCB.20.8.2915-2925.2000] [Cited by in Crossref: 113] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
432 Bishop CL, Bergin AM, Fessart D, Borgdorff V, Hatzimasoura E, Garbe JC, Stampfer MR, Koh J, Beach DH. Primary cilium-dependent and -independent Hedgehog signaling inhibits p16(INK4A). Mol Cell 2010;40:533-47. [PMID: 21095584 DOI: 10.1016/j.molcel.2010.10.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
433 Gillett CE, Barnes DM. Demystified ... cell cycle. Mol Pathol 1998;51:310-6. [PMID: 10193511 DOI: 10.1136/mp.51.6.310] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
434 Sklenovský P, Otyepka M. In Silico Structural and Functional Analysis of Fragments of the Ankyrin Repeat Protein p18 INK4c. Journal of Biomolecular Structure and Dynamics 2010;27:521-39. [DOI: 10.1080/07391102.2010.10507336] [Cited by in Crossref: 71] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
435 Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG. p16/INK4a and p15/INK4b Gene Methylation and Absence of p16/INK4a mRNA and Protein Expression in Burkitt's Lymphoma. Blood 1998;91:1680-7. [DOI: 10.1182/blood.v91.5.1680] [Cited by in Crossref: 68] [Article Influence: 2.8] [Reference Citation Analysis]
436 Simpson DJ, Bicknell JE, Mcnicol AM, Clayton RN, Farrell WE. Hypermethylation of thep16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chromosom Cancer 1999;24:328-36. [DOI: 10.1002/(sici)1098-2264(199904)24:4<328::aid-gcc6>3.0.co;2-p] [Cited by in Crossref: 69] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
437 Oikawa S, Murakami K, Kawanishi S. Oxidative damage to cellular and isolated DNA by homocysteine: implications for carcinogenesis. Oncogene 2003;22:3530-8. [DOI: 10.1038/sj.onc.1206440] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
438 Singh AD, Shields CL, Shields JA, De Potter P. Bilateral Primary Uveal Melanoma. Ophthalmology 1996;103:256-62. [DOI: 10.1016/s0161-6420(96)30707-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
439 Kraniak JM, Abrams J, Nowak JE, Tainsky MA. Antioxidant agents transiently inhibit aneuploidy progression in Li-Fraumeni cell strains. Mol Carcinog 2006;45:141-56. [PMID: 16385586 DOI: 10.1002/mc.20145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
440 Nieländer I, Bug S, Richter J, Giefing M, Ignacio Martín-subero J, Siebert R. Combining array-based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms. APMIS 2007;115:1107-34. [DOI: 10.1111/j.1600-0463.2007.apm_883.xml.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
441 Guo H, Liu F, Zhao J, Chen H. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells. J Cell Biochem 2000;79:370-85. [DOI: 10.1002/1097-4644(20001201)79:3<370::aid-jcb30>3.0.co;2-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
442 Preti M, Seters MV, Sideri M, Beurden MV. Squamous Vulvar Intraepithelial Neoplasia: . Clinical Obstetrics and Gynecology 2005;48:845-61. [DOI: 10.1097/01.grf.0000181738.37911.03] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
443 Mori N, Yang R, Kawamata N, Miller CW, Mizoguchi H, Koeffler HP. Absence of R24C Mutation of the CDK4 Gene in Leukemias and Solid Tumors. Int J Hematol 2003;77:259-62. [DOI: 10.1007/bf02983783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
444 Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, Yi W, Xiao L, Li X, Huang C, Cao L, Tang K, Li X, Shen S, Li G. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 2008;123:2065-72. [PMID: 18697201 DOI: 10.1002/ijc.23727] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
445 Gump J, Stokoe D, McCormick F. Phosphorylation of p16INK4A correlates with Cdk4 association. J Biol Chem 2003;278:6619-22. [PMID: 12529334 DOI: 10.1074/jbc.C200622200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
446 Tada M, de Tribolet N. Immunobiology of malignant gliomas. J Clin Neurosci 1996;3:102-13. [PMID: 18638850 DOI: 10.1016/s0967-5868(96)90001-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
447 Correale J, Gilmore W, Li S, Walsh J, Bassani M, Lund B, Arias M, Weiner L. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS. Journal of Neuroimmunology 2000;109:197-210. [DOI: 10.1016/s0165-5728(00)00326-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
448 Platz A, Ringborg U, Hansson J. Hereditary cutaneous melanoma. Seminars in Cancer Biology 2000;10:319-26. [DOI: 10.1006/scbi.2000.0149] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
449 Faragher RG, Shall S. Gerontology and drug development: The challenge of the senescent cell. Drug Discovery Today 1997;2:64-71. [DOI: 10.1016/s1359-6446(97)83293-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
450 Lange M, Fujikawa T, Koulova A, Kang S, Griffin MJ, Lassaletta AD, Erat A, Tobiasch E, Bianchi C, Elmadhun N, Sellke FW, Usheva A. Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens. Cell Cycle 2014;13:315-23. [PMID: 24240190 DOI: 10.4161/cc.27056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
451 Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003;3:559-70. [PMID: 12894244 DOI: 10.1038/nrc1145] [Cited by in Crossref: 196] [Cited by in F6Publishing: 163] [Article Influence: 10.3] [Reference Citation Analysis]
452 Yalcin A, Serin MS, Emekdas G, Tiftik N, Aslan G, Eskandari G, Tezcan S. Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias. Int J Lab Hematol 2009;31:407-19. [PMID: 18384396 DOI: 10.1111/j.1751-553X.2008.01052.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
453 Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, Bertheau P, Le Rhun E, Bonneterre J, Janin A, Bousquet G. Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes. Oncotarget 2017;8:37332-41. [PMID: 28445153 DOI: 10.18632/oncotarget.16953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
454 Han J, Tsukada Y, Hara E, Kitamura N, Tanaka T. Hepatocyte Growth Factor Induces Redistribution of p21CIP1 and p27KIP1 through ERK-dependent p16INK4a Up-regulation, Leading to Cell Cycle Arrest at G1 in HepG2 Hepatoma Cells. Journal of Biological Chemistry 2005;280:31548-56. [DOI: 10.1074/jbc.m503431200] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
455 Ohtani N, Yamakoshi K, Takahashi A, Hara E. Real-time in vivo imaging of p16gene expression: a new approach to study senescence stress signaling in living animals. Cell Div 2010;5:1. [PMID: 20157424 DOI: 10.1186/1747-1028-5-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
456 Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 1999;18:5311-5317. [PMID: 10498883 DOI: 10.1038/sj.onc.1202998] [Cited by in Crossref: 188] [Cited by in F6Publishing: 192] [Article Influence: 8.2] [Reference Citation Analysis]
457 Richards HW, Medrano EE. Epigenetic marks in melanoma. Pigment Cell & Melanoma Research 2009;22:14-29. [DOI: 10.1111/j.1755-148x.2008.00534.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
458 Harrison DJ, Howie SE, Wyllie AH. Lymphocyte death, p53, and the problem of the "undead" cell. Curr Top Microbiol Immunol 1995;200:123-35. [PMID: 7634827 DOI: 10.1007/978-3-642-79437-7_9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
459 Gu K, Mes-masson A, Gauthier J, Saad F. Analysis of thep16 tumor suppressor gene in early-stage prostate cancer. Mol Carcinog 1998;21:164-70. [DOI: 10.1002/(sici)1098-2744(199803)21:3<164::aid-mc3>3.0.co;2-m] [Cited by in Crossref: 29] [Article Influence: 1.2] [Reference Citation Analysis]
460 Marjon K, Cameron MJ, Quang P, Clasquin MF, Mandley E, Kunii K, McVay M, Choe S, Kernytsky A, Gross S, Konteatis Z, Murtie J, Blake ML, Travins J, Dorsch M, Biller SA, Marks KM. MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis. Cell Rep 2016;15:574-87. [PMID: 27068473 DOI: 10.1016/j.celrep.2016.03.043] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 23.3] [Reference Citation Analysis]
461 Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A, Furuichi Y, Okumura K, Niwa S, Taya Y, Hara E. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev 1999;13:3027-33. [PMID: 10580009 DOI: 10.1101/gad.13.22.3027] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
462 Miladi-abdennadher I, Abdelmaksoud-damak R, Ayadi L, Khabir A, Amouri A, Frikha F, Ellouz S, Frikha M, Sellami-boudawara T, Mokdad-gargouri R. Expression of p16INK4a, Alone or Combined With p53, is Predictive of Better Prognosis in Colorectal Adenocarcinoma in Tunisian Patients. Applied Immunohistochemistry & Molecular Morphology 2011;19:562-8. [DOI: 10.1097/pai.0b013e3182143380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
463 Lindström MS, Klangby U, Inoue R, Pisa P, Wiman KG, Asker CE. Immunolocalization of Human p14ARF to the Granular Component of the Interphase Nucleolus. Experimental Cell Research 2000;256:400-10. [DOI: 10.1006/excr.2000.4854] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
464 Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y, Cordon-Cardo C. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol. 1999;155:105-113. [PMID: 10393843 DOI: 10.1016/s0002-9440(10)65105-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
465 Collins VP. Progression as exemplified by human astrocytic tumors. Semin Cancer Biol 1999;9:267-76. [PMID: 10448114 DOI: 10.1006/scbi.1999.0132] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
466 Baskaran Y, Ang KC, Anekal PV, Chan WL, Grimes JM, Manser E, Robinson RC. An in cellulo-derived structure of PAK4 in complex with its inhibitor Inka1. Nat Commun 2015;6:8681. [PMID: 26607847 DOI: 10.1038/ncomms9681] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
467 Chao DL, Sanchez CA, Galipeau PC, Blount PL, Paulson TG, Cowan DS, Ayub K, Odze RD, Rabinovitch PS, Reid BJ. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett’s esophagus: a long-term prospective study. Clin Cancer Res. 2008;14:6988-6995. [PMID: 18980994 DOI: 10.1158/1078-0432.ccr-07-5063] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
468 Serafini FM, Radvinsky D. The pathways of genetic transformation in cholangiocarcinogenesis. Cancer Genet 2016;209:554-8. [PMID: 27720541 DOI: 10.1016/j.cancergen.2016.07.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
469 Manojlovic Gacic E, Skender-Gazibara M, Soldatovic I, Dundjerovic D, Boricic N, Raicevic S, Popovic V. Immunohistochemical Expression of p16 and p21 in Pituitary Tissue Adjacent to Pituitary Adenoma versus Pituitary Tissue Obtained at Autopsy: Is There a Difference? Endocr Pathol 2015;26:104-10. [PMID: 25678367 DOI: 10.1007/s12022-015-9358-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
470 Dong CX, Deng DJ, Pan KF, Zhang L, Zhang Y, Zhou J, You WC. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int J Cancer. 2009;124:434-439. [PMID: 18821580 DOI: 10.1002/ijc.23891] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
471 Shih YC, Kerr J, Liu J, Hurst T, Khoo SK, Ward B, Wainwright B, Chenevix-Trench G. Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Int J Cancer 1997;70:508-11. [PMID: 9052747 DOI: 10.1002/(sici)1097-0215(19970304)70:5<508::aid-ijc3>3.0.co;2-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
472 Draetta G, Pagano M. Chapter 25. Cell Cycle Control and Cancer. Elsevier; 1996. pp. 241-8. [DOI: 10.1016/s0065-7743(08)60464-9] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
473 Mehramiz M, Ghasemi F, Esmaily H, Tayefi M, Hassanian SM, Sadeghzade M, Sadabadi F, Moohebati M, Azarpazhooh MR, Parizadeh SMR, Heidari-bakavoli A, Safarian M, Nematy M, Ebrahimi M, Ryzhikov M, Ferns GA, Ghayour-mobarhan M, Avan A. Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: A step toward personalized nutrition. Clinical Nutrition 2018;37:254-61. [DOI: 10.1016/j.clnu.2016.12.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
474 Shu S, Yamashita-Kashima Y, Yanagisawa M, Nakanishi H, Kodera Y, Harada N, Yoshimura Y. Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models. Anticancer Drugs 2020;31:241-50. [PMID: 31633500 DOI: 10.1097/CAD.0000000000000853] [Reference Citation Analysis]
475 Palmer A, Epton S, Crawley E, Straface M, Gammon L, Edgar MM, Xu Y, Elahi S, Chin-Aleong J, Martin JE, Bishop CL, Knowles CH, Sanger GJ. Expression of p16 Within Myenteric Neurons of the Aged Colon: A Potential Marker of Declining Function. Front Neurosci 2021;15:747067. [PMID: 34690683 DOI: 10.3389/fnins.2021.747067] [Reference Citation Analysis]
476 Okamoto A, Jiang W, Kim SJ, Spillare EA, Stoner GD, Weinstein IB, Harris CC. Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci U S A 1994;91:11576-80. [PMID: 7972105 DOI: 10.1073/pnas.91.24.11576] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 1.6] [Reference Citation Analysis]
477 Qi FY, Zhang LX, Han CL, Zuo LF, Lin PZ, Guo JW. Up-regulation of cyclooxygenase-2 in carcinogenesis of esophageal epithelia. Shijie Huaren Xiaohua Zazhi 2003; 11(5): 508-511 [DOI: 10.11569/wcjd.v11.i5.508] [Reference Citation Analysis]
478 Murthi KK, Dubay M, McClure C, Brizuela L, Boisclair MD, Worland PJ, Mansuri MM, Pal K. Structure-activity relationship studies of flavopiridol analogues. Bioorg Med Chem Lett 2000;10:1037-41. [PMID: 10843211 DOI: 10.1016/s0960-894x(00)00156-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
479 Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Abbas A, Debruyne FM, Schalken JA. Homozygous deletions of p16INK4 occur frequently in bilharziasis-associated bladder cancer. Int J Cancer 1996;68:183-7. [DOI: 10.1002/(sici)1097-0215(19961009)68:2<183::aid-ijc7>3.0.co;2-u] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
480 Shuyama K, Castillo A, Aguayo F, Sun Q, Khan N, Koriyama C, Akiba S. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer. 2007;96:1554-1559. [PMID: 17453003 DOI: 10.1038/sj.bjc.6603765] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
481 Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Carneiro PC, Ferreira Alves VA, Zerbini MCN, Liberman B, Gomes GC, Kirschner MA. Adrenocortical carcinoma: Clinical and laboratory observations. Cancer 2000;88:711-36. [DOI: 10.1002/(sici)1097-0142(20000215)88:4<711::aid-cncr1>3.0.co;2-w] [Cited by in Crossref: 250] [Article Influence: 11.4] [Reference Citation Analysis]
482 Khambata RS, Panayiotou CM, Hobbs AJ. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Br J Pharmacol 2011;164:584-97. [PMID: 21457229 DOI: 10.1111/j.1476-5381.2011.01400.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
483 Mann DJ, Child ES, Swanton C, Laman H, Jones N. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J 1999;18:654-63. [PMID: 9927425 DOI: 10.1093/emboj/18.3.654] [Cited by in Crossref: 117] [Cited by in F6Publishing: 106] [Article Influence: 5.1] [Reference Citation Analysis]
484 Tone Y, Mamchaoui K, Tsoumpra MK, Hashimoto Y, Terada R, Maruyama R, Gait MJ, Arzumanov AA, McClorey G, Imamura M, Takeda S, Yokota T, Wood MJA, Mouly V, Aoki Y. Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-Conjugated Splice-Switching Oligonucleotides. Nucleic Acid Ther 2021;31:172-81. [PMID: 33567244 DOI: 10.1089/nat.2020.0907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
485 Myong NH. Cyclin D1 overexpression, p16 loss, and pRb inactivation play a key role in pulmonary carcinogenesis and have a prognostic implication for the long-term survival in non-small cell lung carcinoma patients. Cancer Res Treat 2008;40:45-52. [PMID: 19688048 DOI: 10.4143/crt.2008.40.2.45] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
486 Serra A, Gottardi E, Della Ragione F, Saglio G, Iolascon A. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. Br J Haematol 1995;91:625-9. [PMID: 8555065 DOI: 10.1111/j.1365-2141.1995.tb05358.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
487 Daniel M, Tollefsbol TO. Epigenetic linkage of aging, cancer and nutrition. J Exp Biol 2015;218:59-70. [PMID: 25568452 DOI: 10.1242/jeb.107110] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
488 Hirakawa K, Kawanishi S, Matsumoto J, Shiragami T, Yasuda M. Guanine-specific DNA damage photosensitized by the dihydroxo(tetraphenylporphyrinato)antimony(V) complex. Journal of Photochemistry and Photobiology B: Biology 2006;82:37-44. [DOI: 10.1016/j.jphotobiol.2005.08.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
489 Martin P, Leonard JP. Novel therapeutic targets in mantle cell lymphoma. Expert Opin Ther Targets 2007;11:929-40. [PMID: 17614761 DOI: 10.1517/14728222.11.7.929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
490 Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D; POLA Network. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 2019;21:1519-28. [PMID: 31832685 DOI: 10.1093/neuonc/noz124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
491 Keenan SM, Lents NH, Baldassare JJ. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor supresssor protein, activation of E2F, and G1-S phase prgression. J Biol Chem. 2004;279:5387-5396. [PMID: 14645251 DOI: 10.1074/jbc.M310383200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
492 Ghiorzo P, Ciotti P, Mantelli M, Heouaine A, Queirolo P, Rainero ML, Ferrari C, Santi PL, De Marchi R, Farris A, Ajmar F, Bruzzi P, Bianchi-Scarrà G. Characterization of ligurian melanoma families and risk of occurrence of other neoplasia. Int J Cancer 1999;83:441-8. [PMID: 10508477 DOI: 10.1002/(sici)1097-0215(19991112)83:4<441::aid-ijc2>3.0.co;2-r] [Cited by in Crossref: 51] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
493 Shisa H, Yamada Y, Kawarai A, Terada N, Kawai M, Matsushiro H, Hiai H. Genetic and epigenetic resistance of SL/Ni mice to lymphomas. Jpn J Cancer Res 1996;87:258-62. [PMID: 8613427 DOI: 10.1111/j.1349-7006.1996.tb00214.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
494 Ishikawa M, Fujii T, Saito M, Nindl I, Ono A, Kubushiro K, Tsukazaki K, Mukai M, Nozawa S. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer. 2006;16:347-353. [PMID: 16445657 DOI: 10.1111/j.1525-1438.2006.00355.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
495 Jensen TG, Sørensen CB, Jensen UB, Bolund L. Epidermolysis bullosa simplex keratinocytes with extended lifespan established by ectopic expression of telomerase: EBS keratinocytes with extended lifespan. Experimental Dermatology 2003;12:71-7. [DOI: 10.1034/j.1600-0625.2003.120109.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
496 Arendt T. Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience. 2001;102:723-765. [PMID: 11182240 DOI: 10.1016/s0306-4522(00)00516-9] [Cited by in Crossref: 114] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
497 Kanu OO, Hughes B, Di C, Lin N, Fu J, Bigner DD, Yan H, Adamson C. Glioblastoma Multiforme Oncogenomics and Signaling Pathways. Clin Med Oncol 2009;3:39-52. [PMID: 19777070 DOI: 10.4137/cmo.s1008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 57] [Article Influence: 1.2] [Reference Citation Analysis]
498 Mataraza JM, Tumang JR, Gumina MR, Gurdak SM, Rothstein TL, Chiles TC. Disruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice. J Immunol 2006;177:787-95. [PMID: 16818732 DOI: 10.4049/jimmunol.177.2.787] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
499 Scarpin MR, Leiboff S, Brunkard JO. Parallel global profiling of plant TOR dynamics reveals a conserved role for LARP1 in translation. Elife 2020;9:e58795. [PMID: 33054972 DOI: 10.7554/eLife.58795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
500 Roberts PJ, Kumarasamy V, Witkiewicz AK, Knudsen ES. Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows. Mol Cancer Ther 2020;19:1575-88. [PMID: 32546660 DOI: 10.1158/1535-7163.MCT-18-1161] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
501 Carneiro FP, Ramalho LN, Britto-Garcia S, Ribeiro-Silva A, Zucoloto S. Immunohistochemical expre-ssion of p16, p53, and p63 in colorectal adenomas and adenocarcinomas. Dis Colon Rectum. 2006;49:588-594. [PMID: 16575619 DOI: 10.1007/s10350-006-0515-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
502 Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A. Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol. 1996;16:4673-4682. [PMID: 8756624 DOI: 10.1128/mcb.16.9.4673] [Cited by in Crossref: 219] [Cited by in F6Publishing: 102] [Article Influence: 8.4] [Reference Citation Analysis]
503 Hashemi J, Lindström MS, Asker C, Platz A, Hansson J, Wiman KG. A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF. Cancer Letters 2002;180:211-21. [DOI: 10.1016/s0304-3835(02)00027-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
504 Larripa I, Giere I, Slavutsky I, Diaz M. Molecular study of the interferon genes in chronic myeloid leukemia. Leuk Res 1995;19:513-7. [PMID: 7544849 DOI: 10.1016/0145-2126(95)00010-l] [Reference Citation Analysis]
505 Su J, Maller JL. Cloning and expression of a Xenopus gene that prevents mitotic catastrophe in fission yeast. Molec Gen Genet 1995;246:387-96. [DOI: 10.1007/bf00288613] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
506 Franklin DS, Xiong Y. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 1996;7:1587-99. [PMID: 8898364 DOI: 10.1091/mbc.7.10.1587] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 3.9] [Reference Citation Analysis]
507 Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445:851-857. [PMID: 17314971 DOI: 10.1038/nature05661] [Cited by in Crossref: 894] [Cited by in F6Publishing: 819] [Article Influence: 59.6] [Reference Citation Analysis]
508 Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S. DNA intrastrand cross-link at the 5'-GA-3' sequence formed by busulfan and its role in the cytotoxic effect. Cancer Science 2004;95:454-8. [DOI: 10.1111/j.1349-7006.2004.tb03231.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 4.1] [Reference Citation Analysis]
509 Sakashita K, Koike K, Kinoshita T, Shiohara M, Kamijo T, Taniguchi S, Kubota T. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J Clin Invest 2001;108:1195-204. [DOI: 10.1172/jci200113030] [Cited by in Crossref: 55] [Article Influence: 2.6] [Reference Citation Analysis]
510 Assämäki R, Sarlomo-Rikala M, Lopez-Guerrero JA, Lasota J, Andersson LC, Llombart-Bosch A, Miettinen M, Knuutila S. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors. Genes Chromosomes Cancer 2007;46:564-76. [PMID: 17330260 DOI: 10.1002/gcc.20439] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
511 Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jiménez L, Milà M, Kefford RF. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 2001;20:5543-7. [PMID: 11571653 DOI: 10.1038/sj.onc.1204728] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 5.7] [Reference Citation Analysis]
512 Rao GN. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1999;1448:525-32. [DOI: 10.1016/s0167-4889(98)00149-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
513 Bramanti V, Tomassoni D, Grasso S, Bronzi D, Napoli M, Campisi A, Li Volti G, Ientile R, Amenta F, Avola R. Cholinergic precursors modulate the expression of heme oxigenase-1, p21 during astroglial cell proliferation and differentiation in culture. Neurochem Res 2012;37:2795-804. [PMID: 22956150 DOI: 10.1007/s11064-012-0873-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
514 McKenzie H, Becker TM, Scurr LL, Kefford RF, Rizos H. Wild type and melanoma-associated mutant p16(IN4a) proteins do not oligomerize in vivo. Pigment Cell Melanoma Res 2009;22:131-3. [PMID: 19154236 DOI: 10.1111/j.1755-148X.2008.00530.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
515 Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol. 2000;164:144-151. [PMID: 10605005 DOI: 10.4049/jimmunol.164.1.144] [Cited by in Crossref: 144] [Cited by in F6Publishing: 132] [Article Influence: 6.5] [Reference Citation Analysis]
516 Pirkmaier A, Dow R, Ganiatsas S, Waring P, Warren K, Thompson A, Hendley J, Germain D. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma. Oncogene 2003;22:4425-33. [PMID: 12853979 DOI: 10.1038/sj.onc.1206488] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
517 Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL, Montserrat E, Cardesa A, Campo E. p16INK4a Gene Inactivation by Deletions, Mutations, and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin's Lymphomas. Blood 1998;91:2977-84. [DOI: 10.1182/blood.v91.8.2977.2977_2977_2984] [Cited by in Crossref: 225] [Article Influence: 9.4] [Reference Citation Analysis]
518 Reddel RR. Genes involved in the control of cellular proliferative potential. Ann N Y Acad Sci. 1998;854:8-19. [PMID: 9928415 DOI: 10.1111/j.1749-6632.1998.tb09887.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
519 Raizis AM, Van Mater D, Aaltonen LA, Lohmann D, Cheale MS, Bickley VM, George PM, Zhou Y, Rosoff PM. Trilateral retinoblastoma in a patient with Peutz-Jeghers syndrome. Am J Med Genet A 2013;161A:1096-100. [PMID: 23463749 DOI: 10.1002/ajmg.a.35748] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
520 Darbary H, Stoler DL, Anderson GR. Family cancer syndromes: inherited deficiencies in systems for the maintenance of genomic integrity. Surg Oncol Clin N Am 2009;18:1-17, vii. [PMID: 19056039 DOI: 10.1016/j.soc.2008.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
521 Nugroho TT, Mendenhall MD. An inhibitor of yeast cyclin-dependent protein kinase plays an important role in ensuring the genomic integrity of daughter cells. Mol Cell Biol 1994;14:3320-8. [PMID: 8164683 DOI: 10.1128/mcb.14.5.3320-3328.1994] [Cited by in Crossref: 104] [Article Influence: 3.7] [Reference Citation Analysis]
522 Mason A, Wititsuwannakul J, Klump VR, Lott J, Lazova R. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma: Expression of p16 in Spitzoid tumors. J Cutan Pathol 2012;39:1062-74. [DOI: 10.1111/cup.12014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
523 Jahn SC, Law ME, Corsino PE, Rowe TC, Davis BJ, Law BK. Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes. Biochemistry 2013;52:3489-501. [PMID: 23627734 DOI: 10.1021/bi400047u] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
524 Tanaka EM, Gann AA, Gates PB, Brockes JP. Newt myotubes reenter the cell cycle by phosphorylation of the retinoblastoma protein. J Cell Biol 1997;136:155-65. [PMID: 9008710 DOI: 10.1083/jcb.136.1.155] [Cited by in Crossref: 149] [Cited by in F6Publishing: 130] [Article Influence: 6.0] [Reference Citation Analysis]
525 Zhang B, Peng Zy. A minimum folding unit in the ankyrin repeat protein p16(INK4). J Mol Biol 2000;299:1121-32. [PMID: 10843863 DOI: 10.1006/jmbi.2000.3803] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 2.8] [Reference Citation Analysis]
526 Sasaguri T, Ishida A, Kosaka C, Nojima H, Ogata J. Phorbol Ester Inhibits the Phosphorylation of the Retinoblastoma Protein without Suppressing Cyclin D-associated Kinase in Vascular Smooth Muscle Cells. Journal of Biological Chemistry 1996;271:8345-51. [DOI: 10.1074/jbc.271.14.8345] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 2.5] [Reference Citation Analysis]
527 Shackelford RE, Kaufmann WK, Paules RS. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 1999;107 Suppl 1:5-24. [PMID: 10229703 DOI: 10.1289/ehp.99107s15] [Cited by in Crossref: 114] [Cited by in F6Publishing: 120] [Article Influence: 5.2] [Reference Citation Analysis]
528 Turgut S, Ilhan M, Turan S, Karaman O, Yaylim I, Kucukhuseyin O, Tasan E. The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage. In Vivo 2017;31:357-63. [PMID: 28438863 DOI: 10.21873/invivo.11067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
529 Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med 2010;39:793-9. [PMID: 20618617 DOI: 10.1111/j.1600-0714.2010.00909.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
530 Gemin A, Sweet S, Preston TJ, Singh G. Regulation of the cell cycle in response to inhibition of mitochondrial generated energy. Biochem Biophys Res Commun 2005;332:1122-32. [PMID: 15925326 DOI: 10.1016/j.bbrc.2005.05.061] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
531 Coradini D, Pellizzaro C, Marimpietri D, Abolafio G, Daidone MG. Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells. Cell Prolif. 2000;33:139-146. [PMID: 10959623 DOI: 10.1046/j.1365-2184.2000.00173.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
532 Beissert S, Schwarz T. Mechanisms Involved in Ultraviolet Light-Induced Immunosuppression. Journal of Investigative Dermatology Symposium Proceedings 1999;4:61-4. [DOI: 10.1038/sj.jidsp.5640183] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 4.6] [Reference Citation Analysis]
533 Tsuda H, Yamamoto K, Inoue T, Uchiyama I, Umesaki N. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer 2000;82:675-82. [PMID: 10682682 DOI: 10.1054/bjoc.1999.0980] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 2.4] [Reference Citation Analysis]
534 Dębniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Dębniak B, Górski B, Cybulski C, Mędrek K, Mierzejewski M, Masojc B, Matyjasik J, Złowocka E, Teodorczyk U, Lener M, Klujszo-grabowska E, Nej-wołosiak K, Jaworowska E, Oszutowska D, Szymańska A, Szymańska J, Castaneda J, van de Wetering T, Suchy J, Kurzawski G, Oszurek O, Narod S, Lubinski J. CDKN2A common variant and multi-organ cancer risk—a population-based study. Int J Cancer 2006;118:3180-2. [DOI: 10.1002/ijc.21760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
535 Abukhdeir AM, Park BH. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008;10:e19. [PMID: 18590585 DOI: 10.1017/S1462399408000744] [Cited by in Crossref: 253] [Cited by in F6Publishing: 159] [Article Influence: 18.1] [Reference Citation Analysis]
536 Shiraz OB, Galehdari H, Yavarian M, Geramizadeh B. Possible down regulation of the p16 gene promoter in individuals with hepatocellular carcinoma. Hepat Mon. 2011;11:719-723. [PMID: 22235214 DOI: 10.5812/kowsar.1735143x.732] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
537 Tessema M, Lehmann U, Kreipe H. Cell cycle and no end. Virchows Arch 2004;444:313-23. [PMID: 14968363 DOI: 10.1007/s00428-003-0971-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
538 Park DJ, Wilczynski SP, Pham EY, Miller CW, Koeffler HP. Molecular Analysis of the INK4 Family of Genes in Prostate Carcinomas. Journal of Urology 1997;157:1995-9. [DOI: 10.1016/s0022-5347(01)64917-6] [Cited by in Crossref: 17] [Article Influence: 0.7] [Reference Citation Analysis]
539 Meyer JL, Hanlon DW, Andersen BT, Rasmussen OF, Bisgaard K. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: Correlation with biopsy follow-up results. Cancer 2007;111:83-92. [DOI: 10.1002/cncr.22580] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
540 Parroche P, Roblot G, Le Calvez-Kelm F, Tout I, Marotel M, Malfroy M, Durand G, McKay J, Ainouze M, Carreira C, Allatif O, Traverse-Glehen A, Mendiola M, Pozo-Kreilinger JJ, Caux C, Tommasino M, Goutagny N, Hasan UA. TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression. Oncogenesis 2016;5:e244. [PMID: 27454079 DOI: 10.1038/oncsis.2016.49] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
541 Lingbeek ME, Jacobs JJ, van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 2002;277:26120-7. [PMID: 12000749 DOI: 10.1074/jbc.M200403200] [Cited by in Crossref: 126] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
542 Sherr CJ. Principles of tumor suppression. Cell. 2004;116:235-246. [PMID: 14744434 DOI: 10.1016/s0092-8674(03)01075-4] [Cited by in Crossref: 624] [Cited by in F6Publishing: 262] [Article Influence: 34.7] [Reference Citation Analysis]
543 Qiao J, Tian Y, Cheng X, Liu Z, Zhou J, Gu L, Zhang B, Zhang L, Ji J, Xing R, Deng D. CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma. Front Oncol 2021;11:801219. [PMID: 35004325 DOI: 10.3389/fonc.2021.801219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
544 Calaf GM, Bleak TC, Roy D. Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review). Oncol Rep 2021;45:24. [PMID: 33649804 DOI: 10.3892/or.2021.7975] [Reference Citation Analysis]
545 Aubrey Thompson E, Ko TC, Daniel Beauchamp R. TGF-β Inhibition of Intestinal Epithelial Cell Proliferation: G1 Cyclins, Cyclin-Dependent Kinases, and Cyclin Kinase Inhibitors. In: Vedeckis WV, editor. Hormones and Cancer. Boston: Birkhäuser; 1995. pp. 43-71. [DOI: 10.1007/978-1-4612-4266-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
546 Pavel S, Smit NP, van der Meulen H, Kolb RM, de Groot AJ, van der Velden PA, Gruis NA, Bergman W. Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case: . Melanoma Research 2003;13:171-8. [DOI: 10.1097/00008390-200304000-00010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
547 Qin Y, Liu JY, Li B, Sun ZL, Sun ZF. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis. World J Gastroenterol 2004; 10(9): 1276-1280 [PMID: 15112341 DOI: 10.3748/wjg.v10.i9.1276] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
548 Al-Khalaf HH, Colak D, Al-Saif M, Al-Bakheet A, Hendrayani SF, Al-Yousef N, Kaya N, Khabar KS, Aboussekhra A. p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1. PLoS One 2011;6:e21111. [PMID: 21799732 DOI: 10.1371/journal.pone.0021111] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
549 Sakaguchi M, Fujii Y, Hirabayashi H, Yoon H, Komoto Y, Oue T, Kusafuka T, Okada A, Matsuda H. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study. Int J Cancer 1996;65:442-5. [DOI: 10.1002/(sici)1097-0215(19960208)65:4<442::aid-ijc8>3.0.co;2-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
550 Ivinson AJ. p16 and melanoma. Nature 1994;371:180-180. [DOI: 10.1038/371180a0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
551 Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. 1998;1378:F115-F177. [PMID: 9823374 DOI: 10.1016/s0304-419x(98)00017-1] [Cited by in Crossref: 118] [Cited by in F6Publishing: 220] [Article Influence: 4.9] [Reference Citation Analysis]
552 Zhao XY, Sakashita K, Kamijo T, Hidaka E, Sugane K, Kubota T, Koike K. Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. Cytokine 2005;31:203-12. [PMID: 15996479 DOI: 10.1016/j.cyto.2005.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
553 Ottenhof NA, de Wilde RF, Maitra A, Hruban RH, Offerhaus GJ. Molecular characteristics of pancreatic ductal adenocarcinoma. Patholog Res Int. 2011;2011:620601. [PMID: 21512581 DOI: 10.4061/2011/620601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
554 Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf A, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN. Germline Mutations of the CDKN2 Gene in UK Melanoma Families. Human Molecular Genetics 1997;6:2061-7. [DOI: 10.1093/hmg/6.12.2061] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 3.8] [Reference Citation Analysis]
555 Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T, Muto T. Expressions of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res. 1997;88:855-860. [PMID: 9369933 DOI: 10.1111/j.1349-7006.1997.tb00461.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
556 Buchmann AM, Swaminathan S, Thimmapaya B. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein. Mol Cell Biol 1998;18:4565-76. [PMID: 9671466 DOI: 10.1128/MCB.18.8.4565] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
557 Shan Z, Parker T, Wiest JS. Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene 2004;23:6612-20. [PMID: 15208665 DOI: 10.1038/sj.onc.1207857] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
558 Wakino S, Kintscher U, Kim S, Yin F, Hsueh WA, Law RE. Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle Cells. Journal of Biological Chemistry 2000;275:22435-41. [DOI: 10.1074/jbc.m910452199] [Cited by in Crossref: 172] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
559 Taneja P, Zhu S, Maglic D, Fry EA, Kendig RD, Inoue K. Transgenic and knockout mice models to reveal the functions of tumor suppressor genes. Clin Med Insights Oncol 2011;5:235-57. [PMID: 21836819 DOI: 10.4137/CMO.S7516] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
560 Arendt T. Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int J Dev Neurosci 2001;19:231-45. [PMID: 11337192 DOI: 10.1016/s0736-5748(01)00007-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
561 Hilgers W, Rosty C, Hahn SA. Molecular pathogenesis of pancreatic cancer. Hematol Oncol Clin North Am. 2002;16:17-35. [PMID: 12063826 DOI: 10.1016/s0889-8588(01)00005-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
562 Fusco N, Guerini-Rocco E, Del Gobbo A, Franco R, Zito-Marino F, Vaira V, Bulfamante G, Ercoli G, Nosotti M, Palleschi A, Bosari S, Ferrero S. The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations. PLoS One 2015;10:e0144923. [PMID: 26674347 DOI: 10.1371/journal.pone.0144923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
563 Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. J Neuropathol Exp Neurol 2005;64:398-403. [PMID: 15892297 DOI: 10.1093/jnen/64.5.398] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
564 Taylor LA, O'Day C, Dentchev T, Hood K, Chu EY, Ridky TW, Seykora JT. p15 Expression Differentiates Nevus from Melanoma. Am J Pathol 2016;186:3094-9. [PMID: 27855847 DOI: 10.1016/j.ajpath.2016.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
565 Furukawa T, Sunamura M, Horii A. Molecular mechanisms of pancreatic carcinogenesis. Cancer Sci. 2006;97:1-7. [PMID: 16367914 DOI: 10.1111/j.1349-7006.2005.00134.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
566 Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001;2:731-7. [DOI: 10.1038/35096061] [Cited by in Crossref: 648] [Cited by in F6Publishing: 592] [Article Influence: 30.9] [Reference Citation Analysis]
567 Al-Khalaf HH, Mohideen P, Nallar SC, Kalvakolanu DV, Aboussekhra A. The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage. J Biol Chem 2013;288:35511-25. [PMID: 24163379 DOI: 10.1074/jbc.M113.512640] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
568 Robertson KD, Jones PA. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene 1999;18:3810-20. [DOI: 10.1038/sj.onc.1202737] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 3.0] [Reference Citation Analysis]
569 Ohta M, Berd D, Shimizu M, Nagai H, Cotticelli M-G, Mastrangelo M, Shields JA, Shields CL, Croce CM, Huebner K. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int J Cancer 1996;65:762-7. [PMID: 8631588 DOI: 10.1002/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X] [Cited by in Crossref: 54] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
570 Hanes R, Grad I, Lorenz S, Stratford EW, Munthe E, Reddy CC, Meza-Zepeda LA, Myklebost O. Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma. Oncotarget 2016;7:54583-95. [PMID: 27409346 DOI: 10.18632/oncotarget.10518] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
571 Kaldis P, Russo AA, Chou HS, Pavletich NP, Solomon MJ. Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol Biol Cell 1998;9:2545-60. [PMID: 9725911 DOI: 10.1091/mbc.9.9.2545] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 3.1] [Reference Citation Analysis]
572 Han J, Tian P, Liu X, Yao M, Gu J. Inhibition of the growth of human hepatoma cell line bothin vitro andin vivo by transducing CKI genep21 ( WAF-1 ) with GE7 targeting gene delivery system. Sci China C Life Sci 2000;43:663-8. [PMID: 18726362 DOI: 10.1007/BF02882288] [Reference Citation Analysis]
573 Zhou C, Li J, Li Q. CDKN2A methylation in esophageal cancer: a meta-analysis. Oncotarget. 2017;8:50071-50083. [PMID: 28637022 DOI: 10.18632/oncotarget.18412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
574 Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer. 2009;9:153-166. [PMID: 19238148 DOI: 10.1038/nrc2602] [Cited by in Crossref: 2054] [Cited by in F6Publishing: 1951] [Article Influence: 158.0] [Reference Citation Analysis]
575 Bruce JL, Hurford RK Jr, Classon M, Koh J, Dyson N. Requirements for cell cycle arrest by p16INK4a. Mol Cell 2000;6:737-42. [PMID: 11030353 DOI: 10.1016/s1097-2765(00)00072-1] [Cited by in Crossref: 91] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
576 Al-Khalaf HH, Aboussekhra A. p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay. PLoS One 2013;8:e70133. [PMID: 23894605 DOI: 10.1371/journal.pone.0070133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
577 Micheli L, D'Andrea G, Ceccarelli M, Ferri A, Scardigli R, Tirone F. p16Ink4a Prevents the Activation of Aged Quiescent Dentate Gyrus Stem Cells by Physical Exercise. Front Cell Neurosci 2019;13:10. [PMID: 30792628 DOI: 10.3389/fncel.2019.00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
578 He XS, Rong YH, Su Q, Luo Q, He DM, Li YL, Chen Y. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance. World J Gastroenterol 2005; 11(15): 2218-2223 [PMID: 15818729 DOI: 10.3748/wjg.v11.i15.2218] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
579 Chellappan SP, Giordano A, Fisher PB. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol. 1998;227:57-103. [PMID: 9479826 DOI: 10.1007/978-3-642-71941-7_4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
580 Aho U, Zhao X, Löhr M, Andersson R. Molecular mechanisms of pancreatic cancer and potential targets of treatment. Scand J Gastroenterol. 2007;42:279-296. [PMID: 17354106 DOI: 10.1080/00365520601106384] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
581 Beijersbergen RL, Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1996;1287:103-20. [PMID: 8672526 DOI: 10.1016/0304-419x(96)00002-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 42] [Article Influence: 0.8] [Reference Citation Analysis]
582 Ma L, Saiyin H. LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer. PLoS One 2017;12:e0176844. [PMID: 28475592 DOI: 10.1371/journal.pone.0176844] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
583 Collins VP. Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 2004;75 Suppl 2:ii2-11. [PMID: 15146033 DOI: 10.1136/jnnp.2004.040337] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
584 Tlsty TD, Crawford YG, Holst CR, Fordyce CA, Zhang J, McDermott K, Kozakiewicz K, Gauthier ML. Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J Mammary Gland Biol Neoplasia 2004;9:263-74. [PMID: 15557799 DOI: 10.1023/B:JOMG.0000048773.95897.5f] [Cited by in Crossref: 63] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
585 Ansari-lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM. Distinction of Endocervical and Endometrial Adenocarcinomas: Immunohistochemical p16 Expression Correlated With Human Papillomavirus (HPV) DNA Detection. The American Journal of Surgical Pathology 2004;28:160-7. [DOI: 10.1097/00000478-200402000-00002] [Cited by in Crossref: 125] [Cited by in F6Publishing: 94] [Article Influence: 6.9] [Reference Citation Analysis]
586 Park M, Krause M. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex. Development 1999;126:4849-60. [DOI: 10.1242/dev.126.21.4849] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
587 Oikawa S, Hirosawa I, Tada-oikawa S, Furukawa A, Nishiura K, Kawanishi S. Mechanism for manganese enhancement of dopamine-induced oxidative DNA damage and neuronal cell death. Free Radical Biology and Medicine 2006;41:748-56. [DOI: 10.1016/j.freeradbiomed.2006.05.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
588 García-Reyes B, Kretz AL, Ruff JP, von Karstedt S, Hillenbrand A, Knippschild U, Henne-Bruns D, Lemke J. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2018;19:E3219. [PMID: 30340359 DOI: 10.3390/ijms19103219] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
589 Viola JR, Rafael DF, Wagner E, Besch R, Ogris M. Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids. J Drug Deliv 2013;2013:897348. [PMID: 23634303 DOI: 10.1155/2013/897348] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
590 Studzinski GP, Harrison LE. Differentiation-Related Changes in the Cell Cycle Traverse. Elsevier; 1999. pp. 1-58. [DOI: 10.1016/s0074-7696(08)61384-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
591 Höllsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999;63:308-33. [PMID: 10357853 DOI: 10.1128/MMBR.63.2.308-333.1999] [Cited by in Crossref: 87] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
592 Yang K, Oak ASW, Slominski RM, Brożyna AA, Slominski AT. Current Molecular Markers of Melanoma and Treatment Targets. Int J Mol Sci 2020;21:E3535. [PMID: 32429485 DOI: 10.3390/ijms21103535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
593 Mistriotis P, Andreadis ST. Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation. Ageing Research Reviews 2017;37:94-116. [DOI: 10.1016/j.arr.2017.05.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
594 Soos TJ, Park M, Kiyokawa H, Koff A. Regulation of the cell cycle by CDK inhibitors. In: Pagano M, editor. Cell Cycle Control. Berlin: Springer Berlin Heidelberg; 1998. pp. 111-31. [DOI: 10.1007/978-3-540-69686-5_5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
595 Qari MH, Khalil SH, Kambouris M, Meyer BF. Mutation of p16, p21 or cyclin dependent kinase 4 is rare in acute lymphoblastic leukaemia: Mutation of p16, p21 and CDK4 Genes in ALL. British Journal of Haematology 1998;103:467-72. [DOI: 10.1046/j.1365-2141.1998.00974.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
596 Sakano K, Oikawa S, Hiraku Y, Kawanishi S. Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle. Biochemical Pharmacology 2004;68:1869-78. [DOI: 10.1016/j.bcp.2004.06.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
597 Yang AH, Chen JY, Chen BF. The dysregulated glomerular cell growth in Denys-Drash syndrome. Virchows Arch 2004;445:305-14. [PMID: 15232745 DOI: 10.1007/s00428-004-1069-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
598 Ohsawa N, Uchino S, Saito T, Miyahara M, Inoue T, Kitano S. Prognostic significance of loss of heterozygosity on chromosome 9p21–22 in human esophageal cancer. Int J Clin Oncol 1997;2:230-4. [DOI: 10.1007/bf02488997] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
599 Han S, Ahn SH, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy. Breast Cancer Res Treat 2001;70:205-12. [PMID: 11804184 DOI: 10.1023/a:1013047413895] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
600 Shah SJ, Taub JW, Witt TL, Pollock BH, Ding BC, Moore DS, Amylon M, Pullen J, Ravindranath Y, Matherly LH. Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia: p15 and p16 Gene Alterations and DHFR Expression. British Journal of Haematology 2001;113:746-56. [DOI: 10.1046/j.1365-2141.2001.02775.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
601 Tozawa T, Tamura G, Honda T, Nawata S, Kimura W, Makino N, Kawata S, Sugai T, Suto T, Motoyama T. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Cancer Sci. 2004;95:736-740. [PMID: 15471559 DOI: 10.1111/j.1349-7006.2004.tb03254.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
602 Lachat Y, Diserens A, Nozaki M, Kobayashi H, Hamou M, Godard S, de Tribolet N, Hegi ME. INK4a/Arf is required for suppression of EGFR/ΔEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma. Oncogene 2004;23:6854-63. [DOI: 10.1038/sj.onc.1207872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
603 Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM, Greene LA. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol 1998;143:457-67. [PMID: 9786955 DOI: 10.1083/jcb.143.2.457] [Cited by in Crossref: 173] [Cited by in F6Publishing: 194] [Article Influence: 7.2] [Reference Citation Analysis]
604 Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S, Nakamura Y. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 1996;97:625-31. [PMID: 8655143 DOI: 10.1007/BF02281873] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
605 Karsai S, Abel U, Roesch-ely M, Affolter A, Hofele C, Joos S, Plinkert P, Bosch F. Comparison of p16INK4a expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol 2007;211:314-22. [DOI: 10.1002/path.2100] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
606 Fushimi K, Iijima M, Gao C, Kondo T, Tsjui T, Hashimoto T, Mihara K, Namba M. Transformation of normal human fibroblasts into immortalized cells with the mutant p53 gene and X-rays. Int J Cancer 1997;70:135-40. [DOI: 10.1002/(sici)1097-0215(19970106)70:1<135::aid-ijc20>3.0.co;2-j] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
607 Eiriksdottir G, Sigurdsson A, Jonasson JG, Agnarsson BA, Sigurdsson H, Gudmundsson J, Bergthorsson JT, Barkardottir RB, Egilsson V, Ingvarsson S. Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions. Int J Cancer 1995;64:378-82. [PMID: 8550238 DOI: 10.1002/ijc.2910640605] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
608 . Short Communication. Biological Chemistry Hoppe-Seyler 1995;376:431-46. [DOI: 10.1515/bchm3.1995.376.7.431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
609 Quan M, Wang P, Cui J, Gao Y, Xie K. The roles of FOXM1 in pancreatic stem cells and carcinogenesis. Mol Cancer 2013;12:159. [PMID: 24325450 DOI: 10.1186/1476-4598-12-159] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
610 Alhaja E, Adan J, Pagan R, Mitjans F, Cascalló M, Rodríguez M, Noé V, Ciudad CJ, Mazo A, Vilaró S, Piulats J. Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells. Angiogenesis 2004;7:323-33. [PMID: 15886876 DOI: 10.1007/s10456-005-0368-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
611 van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001;69:774-9. [PMID: 11500806 DOI: 10.1086/323411] [Cited by in Crossref: 123] [Cited by in F6Publishing: 107] [Article Influence: 5.9] [Reference Citation Analysis]
612 Takahashi H, Menjo M, Kaneko Y, Ikeda K, Matsushime H, Nakanishi M. Cdk4 Activation Is Dependent on the Subunit Rearrangement in the Complexes. Biochemical and Biophysical Research Communications 2000;267:388-93. [DOI: 10.1006/bbrc.1999.1931] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
613 Lv F, Wu J, Miao D, An W, Wang Y. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. Biochemical and Biophysical Research Communications 2017;486:264-9. [DOI: 10.1016/j.bbrc.2017.03.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
614 Greten FR, Wagner M, Weber CK, Zechner U, Adler G, Schmid RM. TGF alpha transgenic mice. A model of pancreatic cancer development. Pancreatology 2001;1:363-8. [PMID: 12120215 DOI: 10.1159/000055835] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
615 Lang JC, Tobin EJ, Knobloch TJ, Schuller DE, Bartynski KJ, Mountain RE, Nicholson R, DeYoung BR, Weghorst CM. Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope. 1998;108:923-928. [PMID: 9628511 DOI: 10.1097/00005537-199806000-00024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
616 Bartsch DK, Langer P, Habbe N, Matthäi E, Chaloupka B, Sina M, Hahn SA, Slater EP. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families. Clin Genet. 2010;77:333-341. [PMID: 20041885 DOI: 10.1111/j.1399-0004.2009.01352.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
617 Holland EC. A mouse model for glioma: biology, pathology, and therapeutic opportunities. Toxicol Pathol 2000;28:171-7. [PMID: 10669005 DOI: 10.1177/019262330002800122] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
618 Higashi H, Suzuki-Takahashi I, Yoshida E, Nishimura S, Kitagawa M. Expression of p16INK4a suppresses the unbounded and anchorage-independent growth of a glioblastoma cell line that lacks p16INK4a. Biochem Biophys Res Commun 1997;231:743-50. [PMID: 9070885 DOI: 10.1006/bbrc.1997.6181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
619 Albino AP, Fountain JW. Oncogenes and Tumor Suppressor Genes in Cutaneous Malignant Melanoma. Photochem Photobiol 1996;63:412-8. [DOI: 10.1111/j.1751-1097.1996.tb03058.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
620 Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG. p16/INK4a and p15/INK4b Gene Methylation and Absence of p16/INK4a mRNA and Protein Expression in Burkitt's Lymphoma. Blood 1998;91:1680-7. [DOI: 10.1182/blood.v91.5.1680.1680_1680_1687] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
621 Drummond MJ, McCarthy JJ, Sinha M, Spratt HM, Volpi E, Esser KA, Rasmussen BB. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol Genomics 2011;43:595-603. [PMID: 20876843 DOI: 10.1152/physiolgenomics.00148.2010] [Cited by in Crossref: 146] [Cited by in F6Publishing: 139] [Article Influence: 12.2] [Reference Citation Analysis]
622 Schmetsdorf S, Gärtner U, Arendt T. Expression of cell cycle-related proteins in developing and adult mouse hippocampus. Int J Dev Neurosci 2005;23:101-12. [PMID: 15730892 DOI: 10.1016/j.ijdevneu.2004.07.019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
623 Barker FG, Israel MA. The Molecular Biology of Brain Tumors. Neurologic Clinics 1995;13:701-21. [DOI: 10.1016/s0733-8619(18)30014-8] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
624 Stubdal H, Zalvide J, Decaprio JA. Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J Virol 1996;70:2781-8. [DOI: 10.1128/jvi.70.5.2781-2788.1996] [Cited by in Crossref: 74] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
625 Takasaki Y, Yamada Y, Sugahara K, Hayashi T, Dateki N, Harasawa H, Kawabata S, Soda H, Ikeda S, Tomonaga M, Kamihira S. Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation: Clinical Significance of Altered p16 Expression in ATLL. British Journal of Haematology 2003;122:253-9. [DOI: 10.1046/j.1365-2141.2003.04377.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
626 Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci U S A 2000;97:2229-34. [PMID: 10688915 DOI: 10.1073/pnas.050586197] [Cited by in Crossref: 292] [Cited by in F6Publishing: 308] [Article Influence: 13.3] [Reference Citation Analysis]
627 González-Gil C, Ribera J, Ribera JM, Genescà E. The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia. Genes (Basel) 2021;12:79. [PMID: 33435487 DOI: 10.3390/genes12010079] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
628 Solomon MJ. The function(s) of CAK, the p34cdc2-activating kinase. Trends Biochem Sci 1994;19:496-500. [PMID: 7855894 DOI: 10.1016/0968-0004(94)90137-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
629 Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet 1995;10:114-6. [PMID: 7647780 DOI: 10.1038/ng0595-114] [Cited by in Crossref: 199] [Cited by in F6Publishing: 181] [Article Influence: 7.4] [Reference Citation Analysis]
630 Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002;21:6908-14. [DOI: 10.1038/sj.onc.1205834] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
631 Chew I, Post MD, Carinelli SG, Campbell S, Di Y, Soslow RA, Oliva E. p16 Expression in Squamous and Trophoblastic Lesions of the Upper Female Genital Tract: . International Journal of Gynecological Pathology 2010;29:513-22. [DOI: 10.1097/pgp.0b013e3181e2fe70] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
632 Wong Y, Chung T, Cheung T, Nobori T, Yim S, Lai K, Yu A, Diccianni M, Li T, Chang A. p16INK4andp15INK4BAlterations in Primary Gynecologic Malignancy. Gynecologic Oncology 1997;65:319-24. [DOI: 10.1006/gyno.1997.4669] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
633 Kashiwabara K, Oyama T, Sano T, Fukuda T, Nakajima T. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers. Int J Cancer 1998;79:215-20. [PMID: 9645340 DOI: 10.1002/(sici)1097-0215(19980619)79:3<215::aid-ijc1>3.0.co;2-s] [Cited by in Crossref: 53] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
634 Stein GH, Dulić V. Origins of G1 arrest in senescent human fibroblasts. Bioessays 1995;17:537-43. [PMID: 7575495 DOI: 10.1002/bies.950170610] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 3.3] [Reference Citation Analysis]
635 Shambaugh GE, Haines G, Koch A, Lee EJ, Zhou J, Pestell R. Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition. Brain Research 2000;855:11-22. [DOI: 10.1016/s0006-8993(99)02028-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
636 Below JE, Cox NJ, Fukagawa NK, Hirvonen A, Testa JR. Factors that impact susceptibility to fiber-induced health effects. J Toxicol Environ Health B Crit Rev 2011;14:246-66. [PMID: 21534090 DOI: 10.1080/10937404.2011.556052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
637 Zhao X, Wang Y, Wang Y, Li S, Chen P. Oxidative stress and premature senescence in corneal endothelium following penetrating keratoplasty in an animal model. BMC Ophthalmol 2016;16:16. [PMID: 26839109 DOI: 10.1186/s12886-016-0192-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
638 Santos-de-Frutos K, Djouder N. When dormancy fuels tumour relapse. Commun Biol 2021;4:747. [PMID: 34135460 DOI: 10.1038/s42003-021-02257-0] [Reference Citation Analysis]
639 Brady SN, Yu Y, Maggi LB Jr, Weber JD. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 2004;24:9327-38. [PMID: 15485902 DOI: 10.1128/MCB.24.21.9327-9338.2004] [Cited by in Crossref: 116] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
640 Lavin M, Khanna K, Beamish H, Teale B, Hobson K, Watters D. Defect in Radiation Signal Transduction in Ataxia-telangiectasia. International Journal of Radiation Biology 2009;66:S151-6. [DOI: 10.1080/09553009414551981] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
641 Fabbri G, Khiabanian H, Holmes AB, Wang J, Messina M, Mullighan CG, Pasqualucci L, Rabadan R, Dalla-Favera R. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med 2013;210:2273-88. [PMID: 24127483 DOI: 10.1084/jem.20131448] [Cited by in Crossref: 169] [Cited by in F6Publishing: 154] [Article Influence: 18.8] [Reference Citation Analysis]
642 Spatz A, Avril M. Melanoma in Childhood: Review and Perspectives. Pediatr Dev Pathol 1998;1:463-74. [DOI: 10.1007/s100249900064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
643 Goldstein AM, Tucker MA. Screening for CDKN2A mutations in hereditary melanoma. J Natl Cancer Inst 1997;89:676-8. [PMID: 9168176 DOI: 10.1093/jnci/89.10.676] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
644 Cammett TJ, Luo L, Peng Z. Design and Characterization of a Hyperstable p16INK4a that Restores Cdk4 Binding Activity when Combined with Oncogenic Mutations. Journal of Molecular Biology 2003;327:285-97. [DOI: 10.1016/s0022-2836(03)00043-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
645 Fields S, Sternglanz R. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 1994;10:286-292. [PMID: 7940758 DOI: 10.1016/0168-9525(90)90012-u] [Cited by in Crossref: 421] [Cited by in F6Publishing: 166] [Article Influence: 15.0] [Reference Citation Analysis]
646 Todd MC, Langan TA, Sclafani RA. Doxycycline-Regulated p16MTS1 Expression Suppresses the Anchorage-Independence and Tumorigenicity of Breast Cancer Cell Lines that Lack Endogenous p16. J Cancer 2017;8:190-8. [PMID: 28243323 DOI: 10.7150/jca.15481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
647 Scaini MC, Rossi E, de Siqueira Torres PLA, Zullato D, Callegaro M, Casella C, Quaggio M, Agata S, Malacrida S, Chiarion-sileni V, Vecchiato A, Alaibac M, Montagna M, Mann GJ, Menin C, D’andrea E. Functional impairment of p16INK4A due to CDKN2A p.Gly23Asp missense mutation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2009;671:26-32. [DOI: 10.1016/j.mrfmmm.2009.08.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
648 Garcia MA, Muñoz-fontela C, Collado M, Marcos-villar L, Esteban M, Rivas C. Novel and unexpected role for the tumor suppressor ARF in viral infection surveillance. Future Virology 2007;2:625-9. [DOI: 10.2217/17460794.2.6.625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
649 Matsuda Y. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1734-1740 [PMID: 18350604 DOI: 10.3748/wjg.14.1734] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
650 Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002;99:352-60. [PMID: 11992403 DOI: 10.1002/ijc.10321] [Cited by in Crossref: 141] [Cited by in F6Publishing: 124] [Article Influence: 7.1] [Reference Citation Analysis]
651 Reddel RR. A reassessment of the telomere hypothesis of senescence. Bioessays 1998;20:977-84. [DOI: 10.1002/(sici)1521-1878(199812)20:12<977::aid-bies3>3.0.co;2-e] [Cited by in Crossref: 43] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
652 Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 2003;129:589-96. [PMID: 12920579 DOI: 10.1007/s00432-003-0482-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
653 Thunnissen E, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, Dacic S, Lantuejoul S, Russell PA, den Bakker M, Botling J, Brambilla E, de Cuba E, Geisinger KR, Hiroshima K, Marchevsky AM, Minami Y, Moreira A, Nicholson AG, Yoshida A, Tsao MS, Warth A, Duhig E, Chen G, Matsuno Y, Travis WD, Butnor K, Cooper W, Mino-Kenudson M, Motoi N, Poleri C, Pelosi G, Kerr K, Aisner SC, Ishikawa Y, Buettner RH, Keino N, Yatabe Y, Noguchi M. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases. J Thorac Oncol 2017;12:334-46. [PMID: 27998793 DOI: 10.1016/j.jtho.2016.12.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
654 Korgaonkar C, Zhao L, Modestou M, Quelle DE. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol 2002;22:196-206. [PMID: 11739734 DOI: 10.1128/MCB.22.1.196-206.2002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
655 Quesnel B, Fenaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C, Peyrat JP. Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 1995;72:351-3. [PMID: 7640217 DOI: 10.1038/bjc.1995.337] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
656 Wainwright B. Familial melanoma and p16--a hung jury. Nat Genet 1994;8:3-5. [PMID: 7987389 DOI: 10.1038/ng0994-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
657 Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers. Jpn J Cancer Res 2002;93:1107-13. [PMID: 12417040 DOI: 10.1111/j.1349-7006.2002.tb01212.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
658 Silva J, Silva JM, Domínguez G, García JM, Cantos B, Rodríguez R, Larrondo FJ, Provencio M, España P, Bonilla F. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms: Status of the INK4a/ARF locus in breast cancer. J Pathol 2003;199:289-97. [DOI: 10.1002/path.1297] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
659 Golovleva I, Biasotto M, Verpy E, Roos G, Meo T, Tosi M, Lundgren E. Novel Variants of Human IFN-α Detected in Tumor Cell Lines and Biopsy Specimens. Journal of Interferon & Cytokine Research 1997;17:637-45. [DOI: 10.1089/jir.1997.17.637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
660 Muzeau F, Fléjou JF, Thomas G, Hamelin R. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int J Cancer 1997;72:27-30. [PMID: 9212218 DOI: 10.1002/(sici)1097-0215(19970703)72:1<27::aid-ijc3>3.0.co;2-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
661 Gonzalgo ML, Datar RH, Schoenberg MP, Cote RJ. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer. Urologic Oncology: Seminars and Original Investigations 2007;25:228-35. [DOI: 10.1016/j.urolonc.2006.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
662 Iolascon A, Giordani L, Moretti A, Basso G, Borriello A, Della Ragione F. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Hepatology 1998;27:989-95. [DOI: 10.1002/hep.510270414] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
663 Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R; MPT Collaborators. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours. Br J Cancer 2001;85:1383-6. [PMID: 11720478 DOI: 10.1054/bjoc.2001.2068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
664 Lu VM, O'Connor KP, Shah AH, Eichberg DG, Luther EM, Komotar RJ, Ivan ME. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature. J Neurooncol 2020;148:221-9. [PMID: 32385699 DOI: 10.1007/s11060-020-03528-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
665 Mori Y, Kato S, Fujisawa Y, Ohnishi S, Hiraku Y, Kawanishi S, Murata M, Oikawa S. Mechanisms of DNA damage induced by morin, an inhibitor of amyloid β-peptide aggregation. Free Radic Res 2019;53:115-23. [PMID: 30572734 DOI: 10.1080/10715762.2018.1562179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
666 Rowell EA, Walsh MC, Wells AD. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. J Immunol 2005;174:3359-68. [PMID: 15749868 DOI: 10.4049/jimmunol.174.6.3359] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
667 Chaubert P, Burri N, Cousin P, Shaw P. A novel highly informative polyA microsatellite on the telomeric side of the INK4a/ARF locus. Mol Cell Probes 2001;15:183-5. [PMID: 11352600 DOI: 10.1006/mcpr.2001.0352] [Reference Citation Analysis]
668 Huang YC, Saito S, Yokoyama KK. Histone chaperone Jun dimerization protein 2 (JDP2): role in cellular senescence and aging. Kaohsiung J Med Sci 2010;26:515-31. [PMID: 20950777 DOI: 10.1016/S1607-551X(10)70081-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
669 Asioli S, Righi A, Rucci P, Tarsitano A, Marchetti C, Bacchini P, Balbi T, Bertoni F, Foschini MP. p16 protein expression and correlation with clinical and pathological features in osteosarcoma of the jaws: Experience of 37 cases: Predictive and prognostic value of p16 expression in a series of osteosarcomas of the jaws. Head & Neck 2017;39:1825-31. [DOI: 10.1002/hed.24835] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
670 Collins VP. Gene amplification in human gliomas. Glia 1995;15:289-96. [PMID: 8586464 DOI: 10.1002/glia.440150309] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 3.8] [Reference Citation Analysis]
671 Chen YW, Chu HC, Ze-Shiang Lin, Shiah WJ, Chou CP, Klimstra DS, Lewis BC. p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. PLoS One 2013;8:e69389. [PMID: 23894465 DOI: 10.1371/journal.pone.0069389] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
672 Li Y, Wu D, Chen B, Ingram A, He L, Liu L, Zhu D, Kapoor A, Tang D. ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene 2004;23:7355-65. [DOI: 10.1038/sj.onc.1207957] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
673 Nakanishi M, Adami GR, Robetorye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith OM, Smith JR. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci U S A. 1995;92:4352-4356. [PMID: 7753810 DOI: 10.1073/pnas.92.10.4352] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 3.3] [Reference Citation Analysis]
674 Poon RY, Jiang W, Toyoshima H, Hunter T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J Biol Chem. 1996;271:13283-13291. [PMID: 8662825 DOI: 10.1074/jbc.271.22.13283] [Cited by in Crossref: 103] [Cited by in F6Publishing: 113] [Article Influence: 4.0] [Reference Citation Analysis]
675 Richardson E, Stockwell SR, Li H, Aherne W, Cuomo ME, Mittnacht S. Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response. PLoS One 2012;7:e31627. [PMID: 22384045 DOI: 10.1371/journal.pone.0031627] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
676 Gale N, Michaels L, Luzar B, Poljak M, Zidar N, Fischinger J, Cardesa A. Current review on squamous intraepithelial lesions of the larynx. Histopathology 2009;54:639-56. [DOI: 10.1111/j.1365-2559.2008.03111.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
677 Yang B, Guo Z, Huang Y, Zhu S. Codon optimization of MTS1 and its expression in Escherichia coli. Protein Expression and Purification 2004;36:307-11. [DOI: 10.1016/j.pep.2004.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
678 Kanao H, Enomoto T, Ueda Y, Fujita M, Nakashima R, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Kimura T. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Cancer Lett. 2004;213:31-37. [PMID: 15312681 DOI: 10.1016/j.canlet.2004.03.030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
679 Kawana Y, Ichikawa T, Suzuki H, Ueda T, Komiya A, Ichikawa Y, Furuya Y, Akakura K, Igarashi T, Ito H. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Prostate 2002;53:60-4. [DOI: 10.1002/pros.10131] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
680 Ding Q, Li X, Sun Y, Zhang X. Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-429. Cancer Biomark 2019;24:497-508. [PMID: 30909188 DOI: 10.3233/CBM-182222] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
681 Sacks PG. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metast Rev 1996;15:27-51. [DOI: 10.1007/bf00049486] [Cited by in Crossref: 80] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
682 Corchado-Cobos R, García-Sancha N, González-Sarmiento R, Pérez-Losada J, Cañueto J. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. Int J Mol Sci 2020;21:E2956. [PMID: 32331425 DOI: 10.3390/ijms21082956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
683 Shapiro GI, Rollins BJ. p16INK4A as a human tumor suppressor. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1996;1242:165-9. [DOI: 10.1016/0304-419x(95)00011-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
684 Bertelsen AH, Beaudry GA, Stoller TJ, Trotta PP, Sherman MI. Tumor Suppressor Genes: Prospects for Cancer Therapies. Nat Biotechnol 1995;13:127-31. [DOI: 10.1038/nbt0295-127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
685 Cudejko C, Wouters K, Fuentes L, Hannou SA, Paquet C, Bantubungi K, Bouchaert E, Vanhoutte J, Fleury S, Remy P, Tailleux A, Chinetti-Gbaguidi G, Dombrowicz D, Staels B, Paumelle R. p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages. Blood 2011;118:2556-66. [PMID: 21636855 DOI: 10.1182/blood-2010-10-313106] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
686 Endo N, Tashiro E, Umezawa K, Kawada M, Uehara Y, Doki Y, Weinstein I, Imoto M. Herbimycin A Induces G1 Arrest through Accumulation of p27Kip1 in Cyclin D1-Overexpressing Fibroblasts. Biochemical and Biophysical Research Communications 2000;267:54-8. [DOI: 10.1006/bbrc.1999.1927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
687 Benassi MS, Molendini L, Gamberi G, Ragazzini P, Sollazzo MR, Merli M, Asp J, Magagnoli G, Balladelli A, Bertoni F, Picci P. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Int J Cancer 1999;84:489-93. [DOI: 10.1002/(sici)1097-0215(19991022)84:5<489::aid-ijc7>3.0.co;2-d] [Cited by in Crossref: 75] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
688 Ferrándiz N, Caraballo JM, García-Gutierrez L, Devgan V, Rodriguez-Paredes M, Lafita MC, Bretones G, Quintanilla A, Muñoz-Alonso MJ, Blanco R, Reyes JC, Agell N, Delgado MD, Dotto GP, León J. p21 as a transcriptional co-repressor of S-phase and mitotic control genes. PLoS One 2012;7:e37759. [PMID: 22662213 DOI: 10.1371/journal.pone.0037759] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
689 Lee KY, Bae SC. TGF-beta-dependent cell growth arrest and apoptosis. J Biochem Mol Biol. 2002;35:47-53. [PMID: 16248969 DOI: 10.5483/bmbrep.2002.35.1.047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
690 Ahamed S, Foster JS, Bukovsky A, Diehl JA, Wimalasena J. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells. Mol Carcinog 2002;34:45-58. [PMID: 12112322 DOI: 10.1002/mc.10048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]